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This research is motivated by some of the challenges faced by the healthcare 
community in communicating health information to the public and the potential for user-
centered technology design to address some of these limitations.  Each year, thousands 
die or are injured due to adverse-drug events due to both prescription and over-the-
counter medications.  The integration of technology has improved the incidence rate for 
adverse-drug events due to prescription medications. Similarly, personal health records 
and other consumer-based health applications have been shown to be beneficial for 
helping individuals manage their health.  Despite this growing body of research, little to 
no research has been conducted to gauge the possible effectiveness of technology created 
through a user-centered design process to assist consumers in understanding similar 
events due to over-the-counter medications.   
This research explores the implications for the design of interactive technology to 
help older adults understand the possible risk of an adverse drug events resulting from 
taking over-the-counter (OTC) medications. A user-centered design process was 
employed, leveraging various techniques to design technology to assist older adults with 
over-the-counter medication information.  The three studies conducted for this research 
are part of an Exploratory Mixed-Methods Study, designed to identify current practices 
and challenges, identify opportunities for technology integration, and to examine the 
usability and effectiveness of the resultant technological artifacts for assisting older 
adults with over-the-counter medication information.  Data collection included semi-
structure interviews, surveys, questionnaires, and observations.  Results from each study 
 iii 
suggest that the technologies evaluated are useful for assisting older adults with over-the-
counter medication information.  Design recommendations identified throughout each 
phase are presented to provide insight on the technology features found useful and not so 
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Consumer-based Health Information Technology (HIT) design is a growing area 
of interest within the Human-Computer Interaction (HCI) community.   However, 
research within HCI, which focuses on helping consumers understand health information, 
is in its adolescence.  Nonetheless, helping people understand health information is a 
fertile area where applying user-centered design techniques to consumer-based health 
information technology design has been immensely beneficial to better understanding the 
design needs of various populations. This has resulted in the design of Consumer Health 
Informatics (CHI) applications that helps patients and consumers become more 
knowledgeable, involved, and empowered about their personal health.  However, because 
of the inherent complexity of health information and communicating health, several 
challenges still exist.   
This research addresses some of the gaps in knowledge that exist related to 
communicating over-the-counter (OTC) medication information to older adults.  Current 
methods for communicating OTC medication information are paper-based or consist of 
technologies that rely heavily on the same language used by their paper-based 
counterparts.  Further, few studies currently exist that focus on how user-centered CHI 
applications can play a role in helping older adults better understand OTC medications, 
although this is still a major concern among older adults. The major goal of this research 
is to better understand and identify ways in which technology may assist older adults in 
the process of selecting appropriate OTC medications.  Design considerations for a novel 
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technological artifact that could assist older adults in the OTC medication selection 
process were identified. In addition, the feasibility, usefulness, usability, and short-term 
effectiveness of the derived artifact and its components for improving understanding of 
and delivering OTC medication risks and benefits for older adults was evaluated.  
 
STUDY DESIGN 
A three-phase Exploratory Sequential Mixed-Methods Study was conducted to 
better understand how technology might assist older adults in the over-the-counter 
selection process. The three phases of the study were conducted over a 2-year period and 
each phase of the study informed the design of the next phase.  The phases of the study 
are outlined below. 
Phase I: Understanding the Over-the-Counter Information Needs of Older Adults 
The first study examined the current over-the-counter medication needs and 
practices of older adults.  This phase of research was conducted to better understand older 
adults current OTC medication selection practices and any challenges they may have with 
OTC medication information. Participants were required to take OTC medication, 
purchase their own OTC medication and be 65 years of age or older.  Semi-structured 
interviews were conducted with 10 older adults that were recruited over the period of 4 
months.  Interviews were conducted until no new data emerged.  Interviews were audio 
recorded and later transcribed for analysis.  A thematic analysis was conducted and 5 
themes emerged related to the participants’ current OTC medication practices. The 
themes centered around participants 1) information seeking timeline, 2) barriers to 
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identifying OTC medication risks, 3) information needs and concerns, 4) information 
sources and 5) challenges with OTC medication information.  The data was used to 
inform and develop a model of the participants OTC medication selection process. 
 
Phase II: Identifying Design Considerations for Technology to Assist Older Adults 
with OTC Decision-Making 
The second study identified design considerations for supporting older adults 
OTC consumer decision-making through technology.  This phase was conducted to 1) 
conceptualize and design a novel prototype interface that could assist older adults in OTC 
consumer decision-making 2) examine the usability of the prototype for assisting older 
adults in the OTC consumer decision-making task and 3) identify aspects of design that 
might be useful to help older adults in the specific task of selecting OTC medication.  
Participants were required to take OTC medication, purchase their own OTC medication 
and be 65 years of age or older.  Data collection included results of an expert review 
(brainstorming and walkthrough sessions), a round of semi-structured interviews that 
included a total of 7 participants, and hand-written notes of observed participant 
interactions with the paper-based prototype.  Recruitment and data collected occurred 
over a period of 6 months.  Data from expert review were collected through hand-written 
notes and email exchanges.  Data was transcribed and content analysis was used to 
identify usability concerns.  Interviews and participant observation notes were audio 
recorded and later transcribed for analysis.  Thematic analysis was conducted to identify 
key aspects of the design that were found useful by the participants.  Five major themes 
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emerged that centered various features and functionality of the system.  These themes 
included: 1) Guided Persuasion, 2) Personalization, Tailoring, and Decision Support, 3) 
Trust and System Recommendation, 4) Consumer-Friendly Health Language and 5) 
Support for Sharing. 
 
Phase III: Designing and Evaluating a Prototype Translator to Assist Older Adults 
with OTC Decision Making 
The final study examined the feasibility and effectiveness of a prototype translator 
designed to assist older adults with OTC medication information.  The translator was 
designed through a human-centered process in which information needs were gathered 
and later included in a prototype to elicit additional feedback from participants.  The 
results of prior studies were used to inform the design of the translator being examined in 
the proposed study.  Twenty-one older adults, 65 years of age or older, were recruited to 
examine the effectiveness of the translator.  Data for background information, health 
literacy, control beliefs, perceived and actual difficulty of the information, and user 
satisfaction were collected.  Recruitment and data was collected over a period of 3 
months.  Data was collected through the use of 7-point Likert-Items, Questionnaires, and 
observation.  Data was analyzed by using descriptive and inferential statistics and 






Due to the limited research that focuses on designing technology to assist older 
adults with over-the-counter medication information and the novelty of the interface 
being design, the studies presented in this research are exploratory in nature.  The 
research therefore focuses on understanding and identifying challenges, examing how 
technology might address the challenges, and conducting early stage evaluations of the 
technologies designed and implemented to address those challenges in order to direct 
future versions of the prototypes. The contributions of this research are therefore to: 
1. Better understand older adults current over-the-counter medication selection 
practices and challenges, and identify opportunities for technology to assist older 
adults in the over-the-counter medication selection process.  Limited to no 
research exists that focuses specifically on designing technology interventions to 
assist older adults with over-the-counter medication information.  This research 
builds on prior literature in HCI that examines the design of health technologies 
that assists patients with medication related information.  In a preliminary study, 
opportunities were identified for technology to assist older adults with the OTC 
medication selection process. 
2. Conceptualize and design a novel interface for assisting older adults with OTC 
medication information and examine the usability of the novel interface for 
assisting older adults with OTC medication information. In the second phase of 
the study, a novel interface was designed and evaluated for its potential to address 
some of the challenges and barriers older adults face with OTC medication 
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information.  The usability and usefulness of the features of the interface were 
examined and through this process, aspects of the design and technology features 
that are useful for assisting older adults with OTC medication information were 
identified.  
3. Design a prototype translator that delivers simplified OTC medication 
information to older adults and examine the effectiveness of the prototype 
translator for affecting older adults control beliefs, comprehension, and 
satisfaction of OTC medication information and identify opportunities to improve 
the translator.  In the final study presented in this dissertation, the feasibility and 
effectiveness of a prototype translator was evaluated.  Results of the study provide 
insight on the feasibility of the technique for providing simplified information to 
older adults.  In addition, recommendations are provided for improving future 
versions of the translator and similar techniques as well as suggestions for using 












UNDERSTANDING THE OVER-THE-COUNTER MEDICATION NEEDS AND 
PRACTICES OF OLDER ADULTS 
 
DISCLAIMER: A version of this chapter was previously published by the author of this 
dissertation (Martin, A.M., Jones, J.N., Gilbert, J.E. 2013. A spoonful of sugar: 
Understanding the over-the-counter medication needs and practices of older adults. In 
Proc. Pervasive Health 2013. 93-96.). The paper has been re-formatted for inclusion in 
this dissertation. As a European Alliance for Innovation (EAI) endorsed transaction, 
copies of the published paper are freely available with permission for sharing, adaptation, 




Understanding the needs of various stakeholders throughout the design process is 
key for creating consumer health applications that are usable, effective, and useful for the 
people that use them. This paper discusses the findings of an exploratory study aimed at 
understanding the current practices, information needs, and challenges of older adults (65 
years and older) when selecting over-the-counter (OTC) medication.  The context of this 
study lies in understanding older adults with the purpose of identifying opportunities for a 
tailored consumer health application to assist them with selecting appropriate OTC 
medications given their health history.  This research contributes to the understanding of 
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the current practices of older adults as related to OTC medication selection.  In addition, 
this paper provides a discussion of opportunities for future applications to help facilitate 
this task for older adults.  
 
INTRODUCTION  
Each year, thousands die or are injured due to adverse drug events (ADEs) 
resulting from taking medication [1, 2].  Medication interactions (ADEs resulting from a 
reaction to a medication) are considered to be the main cause of ADEs [3]. To this end, in 
recent years, several novel consumer health applications have emerged to support 
consumers in managing or understanding medication information.   In addition, these 
applications have encouraged consumers to become more informed about the medication 
they take.  
This research builds on previous work by providing insight on the processes, 
information needs, and challenges of older adults (65 years and older) when using over-
the-counter (OTC) medication information to make a purchasing decision. OTC 
medication use, compared to prescription, is heavily dependent on the consumer’s ability 
to understand and correctly use the OTC medication given their knowledge of their own 
health.  Emphasis is placed on older adults because certain factors (e.g. lower health 
literacy levels, risk of chronic illness) increase with age thereby increasing the risk of an 
ADE [4, 5].  
Although recent work has focused on understanding users in order to design 
various consumer health applications for medication, little has been done to understand 
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the specific needs of older adults in order to effectively communicate information for the 
purpose of assisting them in the selection of an appropriate OTC medication.  The 
authors define an appropriate medication as one that does not conflict with a chronic 
illness or other medication.  The goal therefore of this exploratory study is to better 
understand the current challenges and needs of older adults in an effort to identify 
opportunities for a consumer health application to help facilitate this task. 
RELATED WORK 
Over the years, several researchers in the healthcare field have conducted studies 
to understand users with the goal of improving user interactions with medication 
information. In 1999, the Food and Drug Administration published the OTC Drug Facts 
regulation as a guide for makers of OTC medication to follow [6].  That same year, 
researchers released the results of a study examining users’ OTC Drug labeling format 
preferences [7].  Following this study, several studies were published that focused on 
different aspects of paper-based medication information design [7-10]. 
Similarly, researchers have used various techniques to better understand users with the 
goal of designing consumer-based applications to assist with different aspects of the 
medication regimen [11-19]. Seik and colleagues looked specifically at the needs of older 
adults to understand the requirements for a personal health application to help them 
manage medication [16].   Wilcox and colleagues examined the needs of cardiology 
patients to design an in-hospital application to provide them with information about their 
care (including medication and treatment) during their stay [17]. Neafsey and colleagues 
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explored the needs of older adults to understand how to design an interactive educational 
intervention to warn about OTC medication and alcohol interactions [18]. 
Although previous work in this area has provided insight on the needs of different 
groups of users for different tasks related to medication, to the knowledge of the 
researchers, no study has focused on understanding the needs of older adults when 
attempting to select (opposed to manage) an OTC medication.  This work builds on 
previous literature by contributing to the understanding of older adults as related to 
selecting an OTC medication. In addition, this research provides a discussion of 
opportunities, based on the findings, for consumer health applications to assist in 




The study was conducted on-site at two locations within the local community.   A 
research team member met and conducted meetings with administrators at each location 
to explain the goals of the study, answer questions, obtain permission to recruit members, 
and to obtain research site letters for the institutional review board (IRB) application. 
Proper IRB approval was obtained before the study began. 
 
Study Location and Participants 
The study was performed at two locations: a senior life-long learning center and a 
local senior activity center.  Participants of the study were members of one of the two 
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organizations.  Participants were recruited by email or through a verbal announcement at 
the center by one of the researchers.  Participants in the study were required to be at least 
65 years of age, purchase or select their own over-the-counter medication and have 
purchased or selected for purchase at least one over-the-counter medication in the past 
year.  
A total of 10 participants were recruited for the study (female = 7, male = 3) with 
ages ranging from 66 - 82 (mean = 74.2, S.D. = 4.685).  Five participants were Caucasian 
and five participants were African-American. One participant had a middle school 
education, one earned a Master’s degree, and one earned a Ph.D. Most participants had at 
least some college education (n=7).   
All 10 participants indicated that they took medication (prescription and over-the 
counter).  When asked how many medications they take on a daily or weekly basis, 
participant responses ranged from 3 – 12 (mean ~ 7).  In addition, all participants 
indicated that they had taken at least one over-the-counter medication within the last year 
(min = 2 daily, max = 5 daily). All participants reported that they primarily purchased 
their own OTC medication, however participants with a significant other reported that 
their spouse would sometimes purchase OTC medication for them. 
 
METHODS 
Semi-structured interviews were conducted with participants. All interviews were 
audio recorded and later transcribed for analysis.   Data were analyzed for emerging 
themes to create an initial coding guide.  Two researchers met several times to discuss 
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emerging themes and make updates to the initial coding guide.  Researchers later used the 
coding guide to independently and thematically code participant responses.  The percent 
of agreement among researchers was greater that 80% for all categories indicating a high-
level of agreement among coders. 
Interview questions were designed to better understand some of the current practices and 
challenges of older adults when choosing an OTC medication.  These questions fit 
broadly into the two categories detailed below. 
1) Current OTC Selection Practices: OTC medication, unlike prescription, does not 
require oversight from a healthcare provider and can be purchased at will by a 
consumer [20].  It was important to get a sense of older adults’ attitudes towards 
OTC medication selection.  Participants were therefore asked questions to 
understand their current selection process, the people involved, and the resources 
they consult. 
2) Challenges with OTC Medication Information: Questions in this category focused 
on understanding some of the challenges older adults face when using OTC 
medication information to make a decision to select or purchase.    Participants 
were asked to describe any challenges they had with medication information in 
the past year.  Participants were also given examples of OTC medication 
information (labels and page from WebMD) and asked to identify and discuss 
anything they found cumbersome or helpful about the information or the 




Participants’ responses to interview questions were categorized into high-level 
themes based on the thematic coding of the interview data. In interviews, at a conceptual 
level, participants described their current OTC medication selection processes. In this 
process, older adults enter one or more states on their journey to selecting an OTC 
medication (See Fig. 2-1). These states provide a basis for the information seeking 
timeline.  When searching for an OTC medication the older is either presented with 
barriers that prevent them from identifying the benefits and risks of the OTC medication 
or is faced with information needs or concerns that trigger a cycle in which the older 
adult seeks information from information sources. In this cycle, if the older adult finds 
the information presented challenging he or she may consult additional information 
sources until an OTC medication is selected. Additionally, once the older adult has 
selected an OTC medication to take, he or she may seek information regarding a 
medication they have already selected.  Each state in this process maps to one of the key-




Figure 2-1. Older adults’ over-the-counter medication selection process. 
 
Information Seeking Timeline 
Of the participants that mentioned that they sought information about their OTC 
medications, some indicated that they would seek this information after first taking the 
OTC medication.  This was due to various factors including timing of scheduled visits 
with their doctors or having taken the medication before. For example, four participants 
mentioned that they felt comfortable asking their doctor about medications during regular 
visits.  P8 stated, “If I have any questions [about an OTC medication], I ask the 
pharmacist and then at my next appointment with the doctor, I will ask the doctor.” 
 
Barriers to Identifying OTC Medication Risks 
The interviews revealed several potential barriers that may prevent older adults 
from identifying OTC medication risks.  One participant expressed his perception that 
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OTC medications generally could not do much harm.  He stated, “You have a feeling, if 
you buy something over-the-counter, it’s probably not going to kill you.  Right?”   
Three participants mentioned that history or familiarity with a medication might 
influence whether or not someone seeks advice about an OTC medication before 
selecting.  P1 stated, “The other thing is, if it’s a person who’s been around for decades, 
and decades, and decades … and they’ve taken Advil their whole life, they’re just going 
to grab a jar of Advil.  You know, you sometimes develop an affinity for a certain pill 
that’s over-the-counter”.  
Finally, six participants indicated they were generally not interested or ignored 
OTC medication information for various reasons. P6 stated, “I look at risks, but I sadly 
have grown to the point of almost ignoring it because they list so many risk and it seems 
though it’s mostly just for liability reasons”. 
 
Information Needs and Concerns 
Participants discussed several pieces of information they found important when 
making a decision about taking an OTC medication.  The top information need discussed 
was medication use mentioned by eight of the ten participants.  Medication use was 
followed by interactions, mentioned by seven of the ten participants.  At least two 
participants discussed brand of medication, side-effects/risks, dosage 
information/directions, ingredients, and price/cost each as important pieces of 
information for making a decision to purchase a medication. One participant discussed 
 16 




Participants indicated a variety of information sources for learning about OTC 
medications.  Several participants expressed that they would consult a doctor or 
pharmacist about an OTC medication.  For example, when asked about the OTC 
medication selection process, Participant 2 (P2) stated, “Well, if I am not sure, I just ask 
the druggist [pharmacist]”. Additionally, P1 expressed concerns about asking the doctor 
or pharmacist about an OTC medication.  She stated, “They [the doctors] are so busy 
now…  The pharmacist is a little bit more available.  I tend not to bother them if the store 
is busy or something.”  Several participants also mentioned consulting friends or family 
(word-of-mouth) or using the OTC medication label.  
Other participants mentioned using some type of technology to help them learn about an 
OTC medication.  For example, P5 stated,  “Speaking for myself, I do have an app on my 
pad that will give me the generic and the … What is it when it’s not generic, when there’s 
a patented name?”  However, when mentioned, the Internet was the primary source for 
searching for medication information.  Most participants however, did not cite a 
technological source for learning about OTC medications. P1 provided an example of 
how she searched for medication information on the Internet, but later stated, “When I’m 
buying something over-the-counter, I usually don’t go into this great detail.” 
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Challenges with OTC Medication Information 
One of the most common challenges discussed with OTC medication information 
was the layout and formatting of the OTC packaging labels.  Eight of the ten participants 
discussed challenges they had with either the size of the text or the organization of the 
information. P4 expressed frustration when searching for the dosage on the OTC 
medication packaging.  He stated, “Where [is the] dosage?  It’s not here.  Okay, you got 
to go on the other side and the dosage is buried in the middle of other things. ‘Stop and 
ask your doctor if you vomit or something’. Well, I would like the directions [and] the 
dosage to be right up front at the beginning.” 
Another common complaint was with the language.  Participants expressed that often 
times they did not understand the information on the label which made it difficult to use.  
P1 stated, “The other thing I see is a problem … I think they said, Don’t take this if you 
are taking other drugs containing prescription or non-prescription NSAIDs… I wouldn’t 
know what an NSAID is unless I Googled it”.   
Participants also discussed challenges with the amount and kind of information 
presented.  P6 stated, “I think too that it’s so complex.  There’s so much to try and read 
and absorb off that label…”.  He later suggested that some types of information were not 
there or not apparent. 
 
DISCUSSION AND CONCLUSIONS 
The findings of this study provide a better understanding of the current practices 
of older adults related to OTC medication selection and reveal several opportunities for 
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technology to assist in this task.  Although some participants in this study did not cite a 
technological source for learning about their OTC medication, their non-use or non-
adoption of current technology may be tied to the perceived benefit (i.e. usefulness) or 
effectiveness of current technology for completing the targeted task [21].  
For example, consistent with other studies, participants in this study expressed 
challenges with the formatting and layout of OTC medication information [7-10]. 
Although prior research has produced guidelines for label formatting and layout, 
understanding that font size is still a concern among older adults, presents the opportunity 
for designers to provide technology that can address this concern  (e.g. tools that provide 
the same information with larger font) and highlight a benefit that is currently not address 
through labeling.   
Given that older adults are at greater risk for adverse drug events due to 
medication, it is imperative that they are aware that there are potential benefits and risk 
and upon this realization, that they can clearly see, find, and understand the information 
provided to make an informed decision [4, 5].  A consumer health application therefore 
has the opportunity to address some of the limitations of labeling, which may help better 
support older adults in the process of selecting appropriate OTC medications.  
Furthermore, careful technology design may also increase awareness of OTC medication 
risks, which can incentivize the use of such technology among the older adult population 




Technology to Support Language Simplification 
Understanding health information is a challenge that is faced by many in the population 
regardless of education level or expertise [4]. Participants of this study also expressed 
challenges with understanding some of the medical terminology used on the label.  
Technology may therefore be useful to bridge the gap between the required medical 
terminology used on the label for accuracy and the layperson terminology desired by the 
consumers for making a decision. Using plain language guides in the design or automated 
techniques (e.g. text simplification) for simplifying language in the application may 
greatly improve the usability of the information for any user, not just older adults. 
 
Technology to Support Awareness 
The findings of this study also imply that some older adults may not be aware of 
the potential risks of OTC medication. Depending on the type of application being 
developed, designers may also consider integrating elements of persuasion into their 
applications.  Persuasive technology design aims to change the attitudes and/or behaviors 
of users through one of seven persuasion techniques: reduction, tunneling, tailoring, 
suggestion, self-monitoring, surveillance, or conditioning [22]. Older adults in this study 
mentioned challenges that can potentially be addressed by one or more of these 
techniques. For example, reduction persuades by simplifying the steps a user takes to 
complete a task.  If the task of finding relevant information can be simplified through 
technology design, older adults may change their attitudes toward seeking OTC 
information in the future. 
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LIMITATIONS AND FUTURE WORK 
Though interviews were conducted until no new data emerged, the study is 
limited by number of people interviewed.  Further work is needed to determine if the 
findings can be generalized to the larger population of older adults.  Future studies will be 
conducted to confirm the usefulness of the opportunities described and to further examine 
ways of addressing the concerns through technology. 
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CHAPTER THREE 
DESIGNING AN OVER-THE-COUNTER CONSUMER DECISION MAKING TOOL 




Older adults are at increased risk of adverse drug events (ADEs) due to 
medication and generally have more difficulty understanding health information. Health 
information technology coupled with effective communication is thought to be beneficial 
to improving many health related tasks.  This paper describes the iterative design process 
of a novel OTC consumer decision-making tool for older adults. Through expert review 
and brainstorming, researchers designed a concept for a novel prototype system to help 
older adults with OTC medication selection.  In addition, older adults users were engaged 
in user sessions to identify usability issues in the prototype system and to identify 
features and functionality that might be useful in system designed to assist with over-the-
counter medications.  Nine usability issues were identified by 7 older adults in the current 
design representing a probability of detection of .917.  This study focuses on identifying 
usability concerns in the initial design and features that older adults find beneficial for 
selecting appropriate OTC medication.  Finally, this paper presents a discussion of how 
early stage usability evaluation helped to refine the design of the resultant technology.  
Additionally, a discussion is presented of how early stage evaluation helped to revise the 
model of how technology support mechanisms may be useful in the OTC decision-




Communicating different types of health information to patients and consumers is 
a huge concern in the public health community (Nielsen-Bohlm, 2004).  Some health-
related tasks, such as choosing an appropriate over-the-counter (OTC) medication, do not 
require direct oversight from a health care provider, which increases the risk of potential 
adverse events for the consumer (Covington, 2006; DeWalt, 2010).  Therefore, it is 
important for consumers to have sufficient health-related knowledge to lessen potentially 
fatal events. 
Thousands of hospitalizations and fatalities occur each year due to adverse drug 
events (ADEs) caused by medication (DeWalt, 2010; Institutes of Medicine, 1999).  
Unlike prescription medication, safe OTC medication use is heavily dependent on the 
consumer’s ability to understand and use the OTC medication appropriately.  In addition, 
consumers view OTC medications differently than prescriptions and generally perceive 
them as harmless (DeWalt, 2010).  Although considerable research has been dedicated to 
better understanding how to design “easy-to-read” labeling for medication, ADEs still 
occur and older adults are at higher risk (United States Food and Drug Administration, 
2009). 
One approach to addressing challenges with communicating health information is 
through health information technology (Healthy People2020, 2020). The design of 
consumer-based health information technology to assist users with health related tasks is 
a growing area within Human-Computer Interaction.  Included in these health related 
tasks are issues that surround the design of medication-related applications for varying 
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groups of users.  This research builds on prior work in this area by focusing specifically 
on the design of technology to facilitate the consumer decision-making process when 
selecting over-the-counter medication.  
 
BACKGROUND 
Consumers often misunderstand OTC or non-prescription medication information, 
which contributes to the large number of adverse drug events occurring each year 
(DeWalt, 2010; Institutes of Medicine, 1999).  There are nearly one hundred thousand 
medications available over-the-counter (Rolita & Freedman, 2008).  Older adults account 
for nearly 40% of all over-the-counter medication use and use twice as many over-the-
counter medications than prescription medications (Conn, 1992).  On average, older 
adults take 6-9 medications concurrently placing them at a higher risk for ADEs.  In 
addition to taking more medication, older adults also tend to have lower health literacy 
levels and are at increased risk for chronic illness, which also contributes to a higher risk 
of adverse drug events (Nielsen-Bohlm, 2004).  Health literacy or the “degree to which 
an individual has the capacity to obtain, process, and understand basic health information 
and services needed to make appropriate health decisions” is noted throughout literature 
as a contributing factor to the success of health communication efforts (Nielsen-Bohlm, 
2004; Warner, Menachemi, & Brooks, 2006).  Adequate health literacy is also central to 
favorable health outcomes (Nielsen-Bohlm, 2004; Warner, Menachemi, & Brooks, 2006). 
Adults 65 years of age and older tend to have on average lower health literacy levels than 
adults younger than 65 (Nielsen-Bohlm, 2004). 
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Many factors affect a person’s ability to understand health information (Nielsen-
Bohlm, 2004).  Among these factors is the way health information is presented to the 
consumers. For older adults, one of the primary challenges with OTC medication is the 
size of the font used on the labels (Martin, Jones, & Gilbert, 2013; Watanabe, Gilbreath, 
& Sakamoto, 1994; William & Wogalter, 1999).  However, formatting, information 
order, external tag placement, and language used may also influence how well OTC 
medication labels communicate information to consumers (Klein & Issacson, 2003; 
Morrow, Weiner, Young, Steinley, & Murray, 2003; Rolita & Freedman, 2008; 
Watanabe, Gilbreath, & Sakamoto, 1994; William & Wogalter, 1999).  
 
RELATED WORK 
In the area of Human Computer Interaction (HCI), research that focuses on the 
design of consumer-based Health Information Technology (HIT) is a growing area of 
concentration.  The main emphasis of HCI is to design technologies from a user-centered 
standpoint to improve the usability of those technologies.  The goals of usability are to 
ensure that technologies are effective, efficient, safe, have good utility, are easy to learn, 
and easy to remember (Preece, Rogers, & Sharp, 2007).  One tenant of HCI is to 
approach the design process with the user’s needs in mind (user-centered design) in order 
to develop technologies that meet the goals of usability.  This tenet is well situated for 
consumer health applications where the consumer’s information needs are important to 
the success of the application. 
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Consumer-Based Technologies for Communicating Medication Information 
Within the area of HCI, approaches to designing consumer-based technologies are 
wide ranging and address a wide range of issues in healthcare, including helping 
consumers with medications.  These technologies can be roughly divided into two 
groups: Health Interfaces and Applications and Physical Devices.  However, the groups 
often overlap.  Prior research on consumer-based technologies involving medication 
provides a foundation for this research and therefore an overview of current trends is 
provided.   
 
Health Interfaces and Applications 
The popularity of the Internet, mobile devices, and other technologies have 
prompted research within HCI that focuses on designing personal health applications and 
interfaces to aid consumers in managing their prescription and OTC medications.  
Making use of mobile devices, personal computers, and other forms of technology, prior 
research has tackled several of the healthcare concerns surrounding patient or consumer-
based medication practices.   
One growing body of research focuses on designing medication compliance and 
management systems to remind patients to take medications and of dosage (Bickmore & 
Jack, 2009; Bickmore, Mauer, Francisco, & Brown, 2008; Hoogendoorn, Klein, & 
Mosch, 2008; Khan, Siek, Meyers & Haverhals, 2010; Qudah, Leidekkers, & Gay, 2010; 
Rodrigo, Cherubini, & Oliver, 2010; Seik et al, 2011; Seik et al, 2010; Silva, Moutthan, 
& Saddik, 2009).  These applications are designed from a patient’s perspective with the 
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goal of improving usability and thereby promoting usage.  Each of these applications 
have varying designs, but they provide the ability for patients to set reminders, enter 
dosage, create medication lists, and/or check potential interactions.  Another body of 
work focuses on helping patients or consumers better understand medications and 
treatments. 
Wilcox and colleagues through participatory efforts, designed personal health 
applications and in-hospital displays to provide hospital patients with information 
regarding their hospital care during their stay (Wilcox, Morris, Tan, Gatewood, & 
Horvitz, 2011).  Interviews with physicians, nurses, and patients were conducted to 
determine the medication information that was important to share with patients 
throughout their stay.  One aspect of this work focuses on providing patients with “micro-
explanations” of the medications they are prescribed and treatments administered while 
in the hospital (Wilcox, Morris, Tan, Gatewood, & Horvitz, 2011).   
Another area of research focuses on designing instructional training systems for 
patients and consumers regarding medication practices.  The goal of these applications is 
to teach users about a particular medication, medication regimen, or medication risks.  
Neafsey and colleagues designed an interactive educational intervention to help active 
older users understand OTC medications and alcohol interactions (Neafsey, Strickler, 
Shellman, & Padula, 2001; Neafsey, Strickler, Shellman, & Chartier, 2002).  Using 
touchscreen notebook computers, the goal of this research was to increase older adults’ 
knowledge of the potential drug interactions between prescription medications; and OTC 
drugs and alcohol (Neafsey, Strickler, Shellman, & Padula, 2001; Neafsey, Strickler, 
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Shellman, & Chartier, 2002).  To address this goal, the researchers created the Personal 
Education Program (PEP), an interactive multimedia computer software program that 
nurse practitioners provided for patients on visits.  Results of this study suggest that users 
of PEP demonstrated a greater self-efficacy or confidence to avoid the adverse 
interactions presented by PEP.    In addition, both users of the control group and of PEP 
were highly satisfied with PEP and indicated that they planned to make changes in self-
medication behavior after using PEP (Neafsey, Strickler, Shellman, & Padula, 2001; 
Neafsey, Strickler, Shellman, & Chartier, 2002).   
Health dialog systems are another form of interface for communicating 
medication information.  A health dialog system is roughly defined as any computational 
system that facilitates communication between a computer and a user (Bickmore & 
Giorgino, 2006).  A simple example of a dialog system is a wizard that guides a user 
through the task of installing some software.  This communication generally involves 
input from the users (e.g. voice, gestures, text, touch) and output from the computer 
system (e.g. spoken language, text).  Timothy Bickmore describes one example of how 
dialog systems can be used to facilitate medical information to patients.  Bickmore and 
colleagues designed a virtual nurse agent to help instruct low health literacy hospital 
patients about their post-hospital care regimen including their medication regimen 
(Bickmore & Giorgino, 2006; Bickmore & Jack, 2009).  The virtual agent and system 
design was informed by the results of UCD process through ethnographic studies, 
interviews with nurses and patients, and usability testing. As a result the overall 
satisfaction level of the virtual nurse was high (94%) (Bickmore & Giorgino, 2006). 
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Physical Devices 
Research aimed at helping consumers understand medication information is not 
limited to interface design.  Physical devices designed to help patients comply and 
manage medication regimes are growing in the area of ubiquitous computing.  
Researchers at the Center for Strategic Technology Research presented a concept of a 
Magic Medicine Cabinet that communicates allergy information and potential 
interactions to users by examining RFID smart labels (Wan, 1999).  Similar devices 
including a “Smart Drawer” and a portable medicine dispenser were created using user-
centered design principles to aid individuals in medication management and compliance 
(Becker et al, 2009; Beer, Keijers, Shahid, Abdullah, & Mubin, 2010). 
Researchers at the University of Baja California designed three ubiquitous 
computing devices (Remind-Me, Guide-Me, and Care-Me) to assist elderly individuals 
with medication management and compliance.   Remind-Me was designed to prompt 
elderly users to take their medications.  Guide-Me provides elderly users with dosage 
information.  Care-Me was designed to make elderly individuals aware of the importance 
of completing medication regimes despite how they may feel (Vazquez, Rodrigues, & 
Andrade, 2010).  Similarly, research concentrating on health monitoring sensor networks 
aims to improve upon existing reminder systems tracking to detect the time, amount, and 
manner in which a medication was taken and alert a patient to stop the regimen when 
adverse events occur (Evers, Wildvuur, & Krose, 2010; Lee & Dey, 2011). 
Building on prior literature, this research proposes that technology designed to 
assist older adults during the process of selecting an OTC medication may also be 
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beneficial to improving understanding and awareness of OTC medication information for 
older adults.  Currently, there is limited research that focuses on how technology can be 
designed to help older adults navigate the decision-making processes of selecting OTC 
medication.   
 
Management, Compliance, and Consumer Decision-Making 
Much of the literature dedicated to the design of medication related technology, 
has focused on medication management or compliance, which although related 
somewhat, is different from the task of consumer decision-making.  Managing a 
medication regimen can be a complex task especially for older adults (Marek & Antle, 
2008; Seik. Khan, Ross, Haverhals, & Meyers, 2011).  At a high-level medication 
management can include any tasks related to buying, taking, and understanding various 
medications (Marek & Antle, 2008).  However, each task presents its own set of 
challenges.  Oftentimes medication management applications are designed to meet one or 
all of the tasks related to medication management.  For example, the design of a 
compliance application or devices typically focus on monitoring whether or not a patient 
has taken his or her medication and whether or not that medication was taken on 
schedule.  Other applications focus on helping patients to schedule medications and/or 
prescription refills by providing users with the ability to create lists to document 
medications, pharmacist, physicians, and alarms/alerts to help them comply with a 
particular regimen.  However, little guidance is available on how to design medication 
applications that focus on helping consumers to make a decision about a medication. 
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Consumer decision-making is concerned with “how consumers develop and use strategies 
for making decisions, how different amounts of prior knowledge influence consumer 
choice processes, how consumers adapt to different decision strategies, and how 
consumers categorize products”(Bettman, Johnson & Payne, 1991).  Further, Bettman 
and colleagues describe a consumer decision-making task as an intricate set of factors 
that requires a consumer to consider the number of alternatives available, attributes of 
value, uncertainty, availability of information in terms of environment and content, and a 
variety of other factors (e.g. importance of the task- what are the consequences of making 
the wrong decision).    In the case of OTC decision-making, there are thousands of OTC 
medications available on the market (hundreds of alternatives) with different attributes of 
values (risks, warnings, dosages, ingredients, etc.) that present tradeoffs.  In the pharmacy 
(environment) the label provides one source of in-environment information.  The 
pharmacist is also a good in-environment information source.  The content provided by 
the label and pharmacist can also provide consumers with additional information about 
tradeoffs of attribute values (e.g. risks, warnings).  However, oftentimes these sources are 
underutilized due to other factors.  For example, the small print on the label has found to 
be a challenge for consumers especially the older adult population (Klein & Issacson, 
2003; Martin, Jones & Gilbert, 2013; Warner, Menachemi & Brooks, 2006).  Similarly, 
understanding health terminology can be challenging and may impact how consumers are 
able to comprehend the OTC medication label (Nielson-Bohlm, 2004; Martin, Jones & 
Gilbert, 2013).  Therefore, the OTC consumer-decision making task can become 
complex.  This research therefore extends, previous research on the design of consumer-
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focused or patient-focused medication applications by exploring the design of a novel 
consumer-decision making tool to assist older adults in this task. To the author’s 
knowledge, no such technology currently exists that focuses specifically on supporting 
older adults’ OTC decision-making.  This research describes the iterative design process 
employed to conceptualize, design, and evaluate a novel interface to assist older adults in 
the task of selecting appropriate over-the-counter medication.   
 
STUDY OVERVIEW 
An exploratory study was conducted to conceptualize and design technology that 
could assist older adults in OTC consumer decision-making. A combination of expert 
review and user sessions with older adults were used to identify tasks, information needs, 
features, functionality, and aspects of the look-and-feel that were important and useful to 
the task of OTC consumer decision making.  The preliminary design of the prototype was 
informed by previous literature on design for older adults and the results of a previous 
study. The preliminary prototype was then evaluated through rounds of expert review.  
Following, older adults evaluated the prototype for usability flaws and discussed features 




An iterative design process was used to conceptualize and design a preliminary 
prototype (See Figure 3-1).  This study is part of a larger Exploratory-Sequential Mixed 
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Method study (Creswell, 2013) and each phase of the study was used to inform the next 
phase. The results of a preliminary study, and literature on design for older adults and 
design of medication related applications were used to develop preliminary prototypes.  
Expert reviewers met to discuss preliminary prototype designs, evaluate the designs 
based on their knowledge of design principles and design for older adults, and examine 
how well the prototype might facilitate the task of OTC consumer decision-making.  In 
addition, older adults were engaged in participatory user sessions to better understand 
features and functionality that might be useful in the task OTC consumer decision-








Preliminary Prototype Design 
Two researchers met over the period of 2.5 months to brainstorm preliminary 
prototype ideas and evaluate the potential for the prototype to facilitate the task of OTC 
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consumer decision-making for older adults.  For the initial prototypes, the researchers 
goals were to explore different ways to address the challenges identified in literature and 
in the preliminary study (See Table 3-1).  Nielsen’s Usability Heuristics were used to 
guide reviews of the system (Nielsen, 1994).  Prototypes ranged from low-fidelity (paper-
based mock-ups) to high-fidelity (PowerPoint decks that included simulated interactions).  
Overall, the researchers aimed to design a persuasive interface.  Prior research indicates 
that many times consumers are unaware of OTC medication risks and may need support 
when navigating OTC medication information (DeWalt, 2010; Martin, Jones & Gilbert, 
2013).  This implies that a persuasive design may be able to address some of the 
challenges and barriers faced by older adults.  The preliminary design therefore included 
aspects of persuasive technology design that could potentially address those challenges. 
 
Initial Design Goal Description/Reasoning 
Support for Medical Terminology Prior research indicates that consumers, in 
particular older adults, may have trouble 
understanding and acting upon health 
information (Hanchate, Ash, Garmararia & 
Paasche-Orlow; Nielsen-Bohlm, 2004; 
Warner, Menachemi & Brooks, 2006).  In 
addition, in interviews with older adults, 
participants identified that they found some 
terms included on the OTC medication 
label challenging. 
Tailored Design for Older Adults Research on the design of medication 
packaging indicates that formatting and 
layout are important factors in how 
consumers use medication information 
(Klein & Issacson, 2003; Morrow, Weiner, 
Young, Steinley, & Murray, 2003; William 
& Wogalter, 1999).  Older adults also 
indicated that formatting such as font-size 
might hinder them from using OTC 
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medication information to make decisions 
(Martin, Jones & Gilbert, 2013).  
Therefore, the design was tailored by 
focusing on formatting, layout, and 
information needs that may be useful to 
older adults. 
Access to Technology Another design goal was to look at 
technologies that could be accessed by 
older adults who may or may not currently 
have access to a computer at home or a 
mobile smart device.  The rationale for this 
is to provide access to technology for a 
group of older adults who may be curious 
or could be persuaded to use technology 
even though they may not have personal 
access for searching for information about 
medication at home or otherwise. 
 
Table 3-1. Initial Design Goals 
Persuasive Technology Design 
Fogg presents two approaches to designing persuasive systems: Macrosuasion and 
Microsuasion (Fogg, 2002).  Macrosuasion is used to describe systems in which 
persuasion and/or motivation are the singular intent of the product.  For example, if a 
system is designed with the sole intent of promoting or motivating a certain behavior.  On 
the other hand, products that are designed with microsuasion in mind do not have an 
overall intent to persuade but instead incorporate persuasive elements to achieve some 
other goal.  Because the overall intent of the system being designed is to assist older 
adults with OTC decision-making, the microsuasion approach was taken by integrating 
varying persuasive technology tools into the design of the system.  Fogg defines 
persuasive tools as an “interactive product designed to change attitudes or behaviors”.  
Seven types of tools have been identified including: Reduction, Tunneling, Tailoring, 
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Suggestion, Self-monitoring, Surveillance, and Conditioning.  Three of those tools were 
applied to the design of this system and are described below. 
 
Reduction 
Reduction (persuasion through simplifying) focuses on making complex tasks 
simpler (Fogg, 2002).  The premise behind reduction technology is that by making target 
behaviors easier, one can increase the benefit/cost ration of performing the behavior 
because humans seek to minimize costs and maximize gains.  Reduction can be 
implemented by minimizing the number of steps it takes to complete a task.  One 
example provided by Fogg is Amazon “one-click” shopping.  The argument is that 
because the number of steps to purchase “thing A” is reduced, consumers will be more 
motivated to buy “thing A”.  For the purposes of this research, simplifying was integrated 
into the prototype by providing support for medication terminology.  Prior research in 
healthcare has identified health literacy as a potential barrier to understanding health 
information.  In addition, in a formative study, older adults identified “complex medical 
terms” as a potential barrier to using OTC medication information.  By providing support 
for simplified information in the system, the goal was to reduce the number of steps and 
time needed to understand the information. 
 
Tunneling 
 Tunneling (guided persuasion) motivates by leading users through a set of steps 
to some goal (Fogg, 2002).  The premise behind tunneling is that it makes it easier to go 
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through the process because the designer controls what the user experiences and also 
supports them through the process.  Similarly, tunneling provides consistency, and it is 
believed that once a person commits to something, he or she will most likely follow 
through.  In the prototype, the system guides the user through the process of determining 
whether or not an OTC medication was appropriate.  The initial interface was designed to 
guide a consumer through the information, highlighting information that should be 
considered in OTC decision-making process, and supporting the user through the process 
by providing access to streamlined and simplified information. 
 
Tailoring 
A tailoring (persuasion through customization) technology provides users with 
relevant individualized information to users to change their attitudes and/or behaviors 
(Fogg, 2002).  The premise behind tailoring is to make the task simpler by highlighting 
information that is relevant to the individual.  Tailored information has been found to be 
more effective than generic information at changing attitudes and behaviors.  The initial 
prototype was designed to provide tailoring through a custom interface designed for older 
adults and through custom information and/or recommendation to the consumer based on 
the input he or she provided to the system. 
 
Brainstorming and Review: Round I 
The first two mockups were designed as search interfaces that augmented the 
information provided on the OTC medication label.  In Mockup A, after typing in a 
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medication name and searching for a medication the user would be presented with a 
tabbed interface that provided information about the medication (See Figure 3-2).  
Mockup B took and more informed approach where users could enter information about 
any chronic illnesses or prescription medication they may have.  The system would 
customize information based on their input.  Users would also be presented with a code 
on their first use so that they could bypass some steps in subsequent interactions with the 
system (See Figure 3-3).  By including information on illnesses and prescription 
medication, users, in addition to the augmented information, would be provided with 
alerts that notify them of a potential adverse interaction. 
 



























































































Evaluation: Round I 
Both mockups were designed to be presented on a multimodal kiosk and provide 
touch input and visual and audio output.  Two HCI researchers evaluated mockups for 
their potential for assisting older adults with OTC consumer decision-making.  Although 
the prototypes addressed several of the initial design goals, researchers identified several 
usability concerns. 
  
• Input method – Typing  (Flexibility and Efficiency of Use) 
Although typing allows users to freely search for any OTC medication, reviewers 
agreed that there might be issues with knowing how to spell certain medications.  
In addition, because the device was being designed for in-pharmacy use, there 
were concerns with the amount of additional time typing would add to the task at 
hand. 
• Amount of Information Presented & Not Enough Guidance (Aesthetic and 
Minimalist Design) 
Tabs were added to provide formatting and to delineate the OTC medication 
information presented by the mockup.  Although, this reduced the amount of 
information presented to the user by some degree, the results of the review 
revealed that additional guidance might be beneficial for older adults.  The 
mockup presented the medication information with settle alerts about things to 
consider.  However, because oftentimes consumers are not aware of the risk of 
OTC medication (DeWalt, 2010), it was decided that the mockups needed more 
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guidance and support to make consumers more aware of things they should 
consider in their decision-making process.  Additionally, it was decided that the 
alerting mechanism was not pronounced enough considering the purpose of the 
technology is to alert older adult of potential risks. 
• Privacy vs. Intelligence (Special Considerations) 
The trade-off between privacy and intelligence was key concern in the 
conceptualization of the initial mockup.  Because the idea was that the technology 
could be accessed in the pharmacy, the researchers were concerned with asking 
users to input information in a public place and also the potential storage of that 
data. Mockup A approached the challenge by not asking users for any personal 
information.  It was designed to only provide information about a selected 
medication and “hints” about potential risks.  Mockup B was designed to allow 
users to type in their current medications and illnesses and the user was then 
provided with a code they could use to bypass these questions in subsequent visits 
to the system.  The mockup would then provide personalized alerts of potential 
risks a user might have.  After reviewing the two mockups, it was decided that 
neither approach A nor B was ideal. Therefore, the researchers agreed that a more 
seamless approach to providing customization while considering privacy was 





Brainstorming and Review: Round 2 
Following the first round of brainstorming and review, a second set of prototypes 
was designed to address the concerns identified in the first review (See Figures 3-4 & 3-
5).  Two prototype versions were designed.  Both were designed as multimodal systems 
that allow touch input and provided both visual and audio output.  The first version was 
designed as a recommender system.  Users could choose conditions they had and/or 
medication they were taking and the system would provide a recommendation of whether 
the medication was appropriate.  Additionally, alternative designs were created that 
included recommendation of other medications that may be appropriate.  The second 
version of the prototype was designed to provide the user with information only.  In this 
version, the system would alert users of any medical conditions and/or medications that 
might interact with the medication.  The following changes were implemented to address 
the concerns identified in the previous review: 
• Input Method – Barcode Scanner 
First, informed by prior work (Seik et al, 2011), a barcode scanner was included 
in the design as an input method to eliminate the need for typing.  By including a 
barcode, users were not required to remember the spelling of medications and the 
amount of time it takes a user to complete a task may be reduced.   
• Guidance and Amount of Information 
To reduce the amount of information presented to the user, information on the 
medication was limited to benefits and potential interactions with medical 
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conditions and medications.  The interface was re-designed to be more persuasive 
and to guide users through the process while highlighting important information. 
• Privacy vs. Intelligence 
To address the trade-off between privacy and intelligence, the new design 
included a degree of customization that did not require users to input information 
about illness and medications directly. Instead of asking users to directly enter 
information on conditions and medication, the system would suggest potential 
illness and medication interactions with the medication.  Users could then select 
any options that apply to their case and the system would use this information to 
provide recommendation about whether or not the medication may be safe to take. 
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Figure 3-5. Information System Prototype 
 
Evaluation: Round II 
A review of the updated prototypes yielded several additional usability concerns.   
First, one reviewer mentioned based on his experience designing touch-based interfaces 
that include checkboxes, that the design of the checkboxes may be a problem 
(Consistency and Standards).  The design was therefore updated to remove obvious 
checkboxes (See Figure 3-6).  Second, there was concern for how the consumer-friendly 
information was presented (Match Between System and the Real World).  The prototype 






















provide the option without altering the original information.  It was also decided that a “I 
AM NOT SURE” option should be included in the list of medications and conditions 
presented to the user to minimize the risk that the user may get stuck if none apply (Error 
Prevention).  Similarly, a “Back” and “Cancel” button was added to each screen to allow 
the users to go back without restarting the process and to provide an exit if needed (User 
Control and Freedom).  Finally, coloring was added to the final screen to provide 
additional notification of the system’s recommendation (Visibility of System Status).   
There was some also concern with links being displayed on a button.  However, it was 
decided to test the concept with users to get feedback. 
 
































In addition to the minor usability concerns, there was still concern about the 
amount of medication information included in the prototype (Aesthetic and Minimalist 
Design).  Therefore, based on a prior study, the prototype was updated to include all 
information included on OTC medication level, but to be presented to the user in chucks 
based on topic (i.e. Inactive Ingredients, Purpose) instead of all at once. 
 
User Sessions with Older Adults 
Following the expert review, the preliminary prototype was evaluated with older 
adults to obtain additional feedback on the usability of the prototype and learn about 
features they find useful to assist with the OTC consumer decision-making task.  Because 
the focus of the technology is a consumer-decision making tool that can be used 
independently by an older adult consumer, participants were purposefully recruited to 
meet several criteria.  Participants were required to be 65 years of age, purchase or select 
their own OTC medication, and have purchased or selected at least one OTC medication 
within the past year.  
Seven older adults volunteered to participate (female = 3, male = 4).  Participants’ 
ages ranged from 65 – 75 (mean = 70, S.D. = 3.1).  Three participants were Caucasian 
and four participants were African-American.  All but two participants had at least some 
college education and all but one participant was retired. Most participants reported 
taking at least one over-the-counter medication per week.  One participant took OTC 
medication every 3 – 4 months.  IRB approval was obtained before the study began.   
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Individual sessions with older adults were conducted on-site at two locations that 
serve older adults populations.   During a session, the participant was presented with a 
mixture or low-fidelity and high-fidelity paper-based prototypes of an OTC consumer 
decision-making technology. Participants were then provided with a verbal scenario and 
were asked to interact with the prototype and walk through an OTC decision-making 
task. The scenario involved a fictional adult that was 65 years old and with a list 
conditions/diseases and medications.  The prototype was presented to participants on an 
iPad device.  The design was informed by previous literature on design for older adults 
and expert review. It mimicked a partially functioning touch-based interface and 
simulated text-to-speech by speaking the words presented on the screen. It guided 
participants through the task of navigating the OTC medication information (See Figures 
4-6).  
Once the participants finished interacting with the prototype, they were asked a 
series of questions in the form of a semi-structured interview.  Interview questions 
centered on several broad categories including: overall like or dislike of the prototype; 
motivations for use; ease of use; language; guidance; trust; and amount of information 
provided. The primary role of the prototype was to act as a technology probe (Hutchinson 
et al, 2003) and discussion point to elicit conversation on the usefulness of the features 
during the interview session. In addition, several alternative paper-based mock-ups were 
used in the interview to encourage discussion of features that were not included in the 
simulated prototype, but were being considered for inclusion by the researchers.  The 
purpose of the alternative mock-ups were to elicit discussion on what additional features 
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participants felt were needed but not included in the current design or features that could 
be removed.  Therefore, the design sessions were not iterative and each participant 
viewed the same prototype throughout the duration of the study.  In addition to responses 
to interview questions, feedback was also collected through observation and direct 
response from participants on any usability and design concerns. 
 
FINDINGS: USABILITY AND DESIGN CONCERNS 
A total of 9 usability issues were identified during the study (See Table 3-2).  Of 
the 9 usability issues that were identified 3 were identified by over half of the participants 
in the study.  A usability issue was defined as anything that prevented the user from 
finishing the task at hand (Tullis and Albert, 2008).  This included anything that caused 
confusion, not seeing something that should be noticed, not understanding the navigation, 
and/or misinterpreting content.  During the study, participants were observed and 
potential usability issues were recorded on printouts of the system’s interface.  The 
researcher considered both verbal and non-verbal expressions made by the participant 
when interacting with the system that might point to usability issues.  In addition, 
usability issues described in the interview transcripts were analyzed and coded.  
Each of the 9 usability issues were rated based on severity to the overall design of 
the system.  A high severity task is any issue that leads to task failure (Tullis and Albert, 
2008).  Two issues were rated as high severity 1) It was not clear how to move to the next 
step in the system and 2) It was not clear how to begin using the system.  Although the 
tasks rated with high severity may not lead to task failure, they may deter use of the 
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system or prevent users from completing task.  Two tasks were rated as medium severity.  
Medium severity tasks contribute to task failure but do not directly prevent task failure 
(Tullis and Albert, 2008).  All other tasks were rated as low severity due to the small 
percentage of participants that identified the issue and/or its overall impact on the system 
design.  








Issue 1 Participant mentioned that 
inactive ingredients are not 
necessary and viewing them 
should be optional. 
4 2 Low 
Issue 2 It was not clear how to move to 
the next step in the system. 
9 4 High 
Issue 3 Once the system has found one 
possible interaction, there is no 
exit and the user must finish all 
steps before getting to the final 
screen. 
2 2 Low 
Issue 4 It was not clear how to begin 
using the system. 
6 6 High 
Issue 5 Participant had trouble selecting 
buttons that listed conditions or 
medications that might interact 
with the medication. 
6 3 Medium 
Issue 6 Participant did not notice links to 
additional information about 
medical terms. 
6 5 Low 
Issue 7 Participant could not turn off 
speech completely. 
2 2 Low 
Issue 8 Participant could not hear voice 
user interface even at the highest 
volume setting. 
5 5 Medium 
Issue 9 Participant attempted to navigate 
the system using his or her voice, 
although speech recognition was 
provided. 
2 1 Low 
 
Table 3-2. Usability Concerns 
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Typically, five participants is recommended for usability testing as nearly 80% of 
usability issues are thought to be observed with the first five participants  (Lewis, 1994; 
Nielsen & Landauer, 1993).  Because, this is an early stage usability test on a novel 
system design, seven participants were recruited to help to refine the design. Data 
gathered from the seven participants reveal that the overall average proportion is 0.49, 
which is the overall probability rate for the test (See Table 3-3).  The probability of 
detection is therefore 0.991.  This suggests that ~99.1% of the usability issues found 




















P1    X  X  X  0.33 
P2 X X  X  X  X X 0.67 
P3    X      0.11 
P4   X X X     0.33 
P5 X X  X X X  X  0.67 
P6 X X X   X X X  0.67 
P7 X X  X  X X X  0.67 
Proportion 0.57 0.57 0.29 0.86 0.29 0.72 0.29 0.72 0.14 0.49 
 
Table 3-3.  Average proportion of usability issues found 
Figure 3-7.  Probability of Detection 
 
Probability	  of	  Detection	  =	  1 − (1 − 𝑝)!	  
identifies	  the	  number	  of	  users	  needed	  to	  identify	  a	  certain	  percentage	  of	  
usability	  issues	  
where	  	  𝑝	  is	  the	  average	  proportion	  for	  a	  test	  and	  𝑛	  is	  the	  number	  of	  users	  
• 1 − (1 − 𝑝)!	  
• 1 − (1 − 0.49)!	  
• 1 − (0.51)!	  
• 1 − 0.0089741	  




Interviews with older adults continued until no new insights were gained. 
Participants’ interview responses were transcribed, coded, and analyzed for recurring 
themes.  One researcher analyzed data initially to create a coding guide.  Afterward, two 
researchers met several times to discuss the guide and update it based on their 
independent views of the data.  The researchers then used the guideline to code the 
interview transcripts. NVivo 10 was used for final coding and analysis and a coding 
comparison of all themes yielded an average percent agreement of 99.176% and an 
average Kappa of .851746 indicating excellent agreement.  Five design considerations 
were identified that participants found useful to help with the tasks of selecting 
appropriate over-the-counter medication. 
 
Tunneling - Guided Persuasion 
The prototype was designed to guide participants through the process of selecting 
an OTC medication (See Figure 3-3).  Varying information about the medication was 
highlighted at each step of the process, participants provided input about conditions and 
medications and at the end a decision of whether or not the medication was appropriate 
was provided.  The information highlighted in the prototype was based on the Federal 
Drug Administration Drug Facts guidelines and was presented in chunks based on the 
grouping presented in the guidelines.   As mentioned earlier, the interface was designed 
purposefully to provide tunneling or guided persuasion in order to motivate consumers to 
use OTC medication information in the OTC decision-making task.  When asked to 
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discuss the wizard-like interface, all participants in the study (n=7) expressed a favorable 
impression of the wizard concept.  For example, Participant 1 commented on the 
usefulness of the approach: 
“I like the wizard approach, stepping people through and going down different 
paths depending on the response” (P1) 
 
In short, participants discussed that having the system guide them through the 
process of selecting a medication was something they viewed as beneficial for the 
prototype and useful for helping with an OTC decision-making task.   
 
Personalization, Tailoring, and Decision Support 
Although the prototype was tailored to the design needs of older adults, the 
original prototype provided a limited degree of personalization.  Participants were 
presented with conditions and medications that might potentially conflict with the OTC 
medication that they were considering and were asked to check any that apply.  While 
most participants liked this approach, it only acted as a data gathering step to provide data 
to the prototype’s decision support algorithm.  However, some participants suggested that 
the system should have an option for providing a higher degree of customization at the 
individual level.  Participant 4 stated: 
“My wife has a thing called Sweet’s syndrome.  She can’t take any steroids.  I 
believe one of the things in here was some sort of steroid, as an inactive ingredient.  One 
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of the things … you need to have a person maybe list the conditions that they have at the 
beginning so that they can weed out the medications that they definitely can’t take.” (P4) 
 
Similarly, when asked if she felt the prototype provided enough information, 
another participant stated: 
“It didn’t say this medicine may affect people who have diabetes … It should be 
listed if it’s going to interfere with people with diabetes I think it should be listed.” (P3) 
 
The condition mentioned by Participant 4 was not included in the warnings 
section of the medication box and therefore was not included in the prototype.  However, 
some participants discussed in the interview that they wanted more individualized 
information.  Participants discussed having the ability to input information about 
medications or conditions before using the system.  Others mentioned going beyond the 
information on the label to include other information such as potential 
condition/ingredient interactions that may not be specifically stated on the label, which 
suggests another degree of reasoning of the data that was not provided by the prototype at 
the time of this study. 
 
Trust and System Recommendation 
To spark discussion in the interview sessions, alternative screen mock-ups were 
included that only provided participants with information about an OTC medication they 
were considering.  In comparison with the high-fidelity prototype in which the participant 
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first interacted, the alternative mockup did not prompt the user to select any medications 
or conditions they had or were taking; and did not provide a recommendation of whether 
the medication was appropriate. 
To the surprise of the researchers, all participants (n=7) indicated a system that 
provided a recommendation would be more beneficial to them than a system that 
provided information only.  The researchers were torn on whether or not users would 
trust or find a recommendation provided by a machine useful.  This is a well-known 
concern when designing persuasive technology (Fogg, 2002).  However, when asked, all 
participants (n=7) indicated they would be comfortable acting on a recommendation 
made by the system and preferred the prototype that made a recommendation over the 
prototype that only provided information. On the other hand, most participants also 
discussed the need for a stronger disclaimer/language to ensure consumers would be 
aware that the system did not replace the advice of a medical professional.  
Participants also talked about the benefit of having the system provide alternative 
medication options if the medication they selected was not appropriate.  This feature was 
provided as an alternative to receiving a message stating that the medication is not 
appropriate.  All participants (n=7) preferred to receive recommendation of other 
medications that might be appropriate as opposed to a “not appropriate” message only. 
 
Consumer-Friendly Health Language 
The prototype provided consumer-friendly explanations of different medical 
terms with the goal of helping participants better understand the overall risks or warnings 
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being presented to them.  This was an attempt to simplify the medication information and 
motivate consumers to complete the task.  Although most participants did not notice this 
option when interacting with the prototype, all participants later indicated that the 
consumer-friendly explanations of medication terms would be beneficial to helping them 
better understand the information if they needed it.   Participant 4 stated: 
“I think people would know I’m taking something for anxiety or I’m taking 
something for depression.  They may not even remember the name of it.  I don’t pay 
attention.  I take blood pressure medication and cholesterol medication.  When I fill out a 
form what medication I’m on, I can’t remember.” (P4) 
 
Another participant discussed his frustration with medication information and 
why he felt language support was useful: 
“It’s intimidating because it’s so much information and what am I supposed to do 
with it?  Am I supposed to understand it? Am I supposed to recognize those chemicals?  
It’s a bit intimidating.” (P6) 
 
Although most participants indicated that they found the language support useful, 
the interview data also reveals that more attention needs to be paid to how consumer-
friendly language can best assist in the task at hand.  For example, most participants did 
not think that the inactive ingredients needed explanation although they too can be seen 
as complex medical terms.  On the other hand, some participants describe that they would 
like to be alerted of potential interactions with ingredients.  Most participants indicated 
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that the explanations provided about medications in the warnings section were useful but 
data reveal that the concept of providing consumer-friendly language should be further 
studied to understand what information should be included, the language that should be 
used, and how to increase the visibility of the feature.   
 
Support for Sharing 
Initially, the prototype presented to the participants did not include any options 
for sharing information about an OTC medication selection or the results obtained from 
the system.  However, interview data revealed that options for sharing the information 
provided by the system might not only be helpful for making an independent decision, 
but also for initiating discussions with the pharmacist or doctor.  The words doctor, 
pharmacist, drugstore man, and druggist (pharmacist) were mentioned 34 times by 
participants over all interview data.  Six of the seven participants discussed that they may 
talk with a doctor or pharmacist in addition to using the system, if they had follow-up 
questions or were still unsure about a medication.    Participant 5 stated: 
“I mean, you’re always going to need the pharmacist’s help, … but this would 
help you… that would save … you can find a lot of stuff yourself” (P5). 
The other five participants made similar comments in their interview.  This 
suggests that the system was viewed as designed, a supplement (not a replacement) to the 
doctor or pharmacist.  However, the data also reveals the importance of providing users 
with information that can assist in their conversations with the doctor and/or pharmacist.  
This feature was not considered as a primary concern in the preliminary design.  
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However, interviews suggest that providing sharing options that support communication 
between the consumer, doctor and/or pharmacist may also be beneficial to assisting in the 
decision-making process.  Keeping the consumer informed helps them to become more 
knowledgeable and aware of their own medication management practices.  This can help 
to create an informed consumer that comes to the conversation more ready to participate. 
Sharing also provides the doctor with information on how his or her patient’s medication 
practices at home and helps to facilitate a conversation in which the consumer already has 
some knowledge or stake. 
 
DISCUSSION AND CONCLUSION 
Including older adults in the early stages of design for this novel technology 
helped to refine the initial prototype design and also helped to refine the initial model of 
how technology can be used to support older adults in this task (See Figures 3-8 & 3-9). 
 




Figure 3-9. Revised Model of OTC Decision-Making Technology Support Mechanisms 
 
Initially, the prototype included four types of technology support mechanisms in 
the design.  The initial design included the concept of tunneling or guiding the user 
through a set of defined steps.  This helped to highlight information that was important 
for older adults to consider when selecting an over-the-counter medication.  The 
prototype was designed for the older adult population using guidelines (e.g. font-size) 
that are suited for the older population.  In addition, the design included consumer-
friendly health language provided through automatic generated explanations of health 
terms and decision support of whether or not a medication was appropriate given the 
users input. Obtaining feedback from older adults helped to refine this model by 
identifying other ways technology could support the OTC decision-making process. 
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In addition to the initial support mechanisms, data revealed that technology could 
also be helpful by providing the user with system recommendations through information 
filtering of user data to predict other medications that may be appropriate.  Users 
expressed that they would also be interested in having more control over the system’s 
input and output.  Some participants expressed the need for a more individualized level of 
personalization by allowing input of information about chronic illnesses or medications 
to help refine the decision support.  Similarly, some participants also discussed going 
beyond the information on the box to include other information about potential 
interactions that might be beneficial to the decision-making process.  This also included a 
suggestion for including an additional level of reasoning for identifying potential adverse 
reactions to the medications ingredients.  Finally, because nearly all users stressed the 
importance having the option to keep the pharmacist/nurse/or doctor in the over-the-
counter medication process in some way, user-controlled information sharing was added 
to the model to not only support consumers in the decision-making process, but also to 
help facilitate discussions about potential OTC medications with persons of their 
choosing. 
Helping consumers understand health information is a challenging task (Nielsen-­‐‑
Bohlm,  2004).  OTC medications are of particular concern among older adults, however 
some believe that technology can help address this challenge (Healthy People, 2010; 
Martin, Jones and Gilbert, 2013; Neafsey, Strickler, Shellman and Chartier, 2002).  The 
goal of this study was to refine the design, understand, and explore technology features 
that may be beneficial to assisting older adults in this task. Through expert review and 
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brainstorming, researchers designed a concept for a novel prototype system to help older 
adults with OTC medication selection.  In addition, seven older adults users were 
engaged in user sessions to identify usability issues in the initial prototype system and to 
identify features and functionality that might be useful in system designed to assist with 
over-the-counter medications.  Nine usability issues were identified by 7 users in the 
current design representing a probability of detection of .917.  Therefore, 99.1% of 
usability issues would be identified with the 7 users included in the study.  In addition, 
five design considerations were identified for technology to assist older adults in the task 
of selecting appropriate OTC medications. 
 
LIMITATIONS AND FUTURE WORK 
The results of this study provide discussion of the process of designing an 
interface that supports older adults in the OTC medication decision-making process.  
Through user sessions with older adults, existing usability concerns were identified 
(Tullis and Albert, 2008).  In addition, qualitative data was collected to identify ways 
technology can support older adults in the over-the-counter decision-making process. 
Because no such technology currently exists for assisting older adults in these tasks, it 
was important to gain feedback early in the design to understand what features and 
functionalities provided by technology would be most supportive in this task.  The study 
included several rounds of expert review and interviews with seven participants (age 
65+), which is more than the recommended number of participants for usability testing 
(Lewis, 1994; Nielsen & Landauer, 1993). A rich, thick description (Creswell, 2013) of 
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the study and its participants is provided and although user sessions were conducted until 
no new data emerged from the accompanying interview with participants, the study may 
be limited by number of people interviewed.  Therefore, additional studies will be 
performed on the revised prototype to determine if the findings of this study can be 
generalized to a larger population. 
The design considerations, feedback, and model identified in this study will be 
used to inform the design of current and future technologies developed to help with OTC 
decision-making tasks. The data from the expert review and study with older adults 
revealed several opportunities for technology to support older adults in the OTC decision-
making tasks. The new model will be used to guide design changes in the current 
prototype interface and to guide the implementation and study of other technology 
support mechanism (e.g. decision support algorithm, health text-simplification approach) 
that will be included in the system implementation. Although many of the features 
identified relate specifically to the task of selecting appropriate over-the-counter 
medications, some considerations may be useful to the design of other consumer-decision 
making applications for older adults. 
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DESIGNING AND EVALUATING A PROTOTYPE TRANSLATOR TO SUPPORT 




Understanding health information is a huge public health concern that affects 
many in the population.  Every year thousand are injured or die due to adverse 
medication interactions. Over-the-counter medication (OTC) can be purchased at will by 
consumers and contribute to a number of adverse medication interactions.  Older adults 
are at higher risk of adverse medication interactions due to factors related to aging.  
Technology is thought to be advantageous for communicating health information to 
various users.  Further, technology that is customized to the needs of the target population 
has been found to improve health outcomes.   
This study evaluates the feasibility of a prototype translator designed through a 
human-centered process that simplifies over-the-counter medication information for older 
adults. This study is part of a larger Exploratory Sequential Mixed-Methods study that 
aims to understand how technology can be used to improve the understanding of OTC 
medication among the older adult population.  The effectiveness of the prototype 
translator for providing patient-centered information about OTC medication compared to 
information that does not use the translator was evaluated.   Older adults were asked to 
participate in an experiment that examines the effect of the translator on the participant’s 
beliefs about the difficulty of the information.  The experiment followed a within study 
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design.  Perceived difficulty of the information, participants’ confidence in using the 
information and their belief about how much control they have over using the 
information to complete the tasks was measured.  In addition, participants were asked to 
answer comprehension questions to determine if the technique makes the process of 
understanding the information less difficult.  Results suggest that the prototype translator 
may improve beliefs about self-efficacy, the participants preferred using the translator, 




Helping consumers understand health information is a sizable public health 
concern (Nielsen-Bohlm, 2004).  In a non-clinical setting, consumers often rely on clear, 
easy to understand health information to make important decisions regarding their health.  
Tasks such as choosing appropriate over-the-counter medication (OTC) become 
primarily the responsibility of the consumer.  Quality measures exist to support consumer 
safety and improve consumer knowledge but gaps in communication still exist putting 
consumers at risk (DeWalt, 2010; Institutes of Medicine, 1999).  This research focuses on 
improving the communication of OTC medication information to the older adult 
population. 
Advances in technology provide new opportunities and mediums for 
disseminating and communicating medication information to various user groups. 
Coupling effective communication with health information technology is thought to 
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improve the consumer experience irrespective of computer skills, and may lead to 
improved health outcomes (Radvan, Wigger, & Hazell, 2004).  To date, researchers have 
explored ways of designing computer-based medication interventions that can assist 
various populations with different aspects of their medication management regimen 
including: scheduling, ordering, compliance or adherence, concordance and/or 
medication education (in-hospital or at home) (Bickmore, Pfeifer and Jack, 2009; 
Hoogendoorn, Klein, and Mosch, 2008; Qudah, Leijdekkers, and Gay, 2010; de Oliveira, 
Cherubini, and Oliver, 2010; Silva, Mouttham, and El Saddik, 2009; Siek et al,  2011; 
Wilcox, Feiner, Liu, Restaino, Collins, and Vawdrey, 2012;  Neafsey, Strickler, Shellman 
and Chartier, 2002; Harjumaa, Isomursu, Muuraiskangas,  and Konttila, 2011).  However 
little to no research has focused on the specific task of OTC decision-making especially 
among the older adult population. Like some of the other medication management tasks, 
OTC decision-making requires the consumer or another vested party to take on a role that 
a healthcare provider might administer in a clinical setting (e.g. administering 
medication, ordering medication).  However, this task is unique in that, the consumer or 
other vested party must also take on the task of understanding the medication information 
provided, the benefits and risk, how the medication may or may not fit into his or her 
existing regimen, and/or how the medication may affect his or her existing health all with 
little or no healthcare provider oversight (DeWalt, 2010; Institutes of Medicine, 1999). 
The consumer in some way takes on a role that is similar to a healthcare provider but may 
not have the training of a healthcare provider.   For older adults, the task of choosing 
appropriate OTC medication is made more complex due to factors related to the natural 
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process of aging.  Therefore, this study extends previous research by taking a first step at 
exploring ways technology may be useful in the OTC decision-making process for older 
adults.  The study will evaluate the feasibility of a prototype translator that was designed 
to address one of the barriers to communicating OTC medication information, complex 
medical terminology, identified in a preliminary study with older adults. 
This study was conducted in locations within the local community with adults 65 
years and older.  Community dwelling older adults were chosen because the prototype 
translator used in this study is being evaluated for use in an intervention tailored to the 
needs of older adults that select or purchase their own OTC medication.   Older adults 
participated in an experiment that examined 1) perceived difficulty, self-efficacy, and 
controllability 2) comprehension and 3) actual difficulty.  Well-developed measures for 
evaluating information difficulty and OTC medication comprehension were used.  In 
addition, observational measures (event coding and task completion of comprehension 
questions) were recorded and an informal questionnaire was administered at the end of 
the interview to collect information preferences, helpfulness, and suggested 
improvements. Therefore the specific aims of this study were to: 
1. Evaluate the feasibility and effectiveness of a prototype translator designed to 
reduce the difficulty of OTC medication information for community-dwelling 
older adults. 
2. Identify additional opportunities for the prototype translator to reduce the 
difficulty of OTC medication for older adults. 
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BACKGROUND AND RELATED WORK 
Over-the-Counter Medication and Consumer Safety 
Every year thousands die or are injured due to adverse drug events (ADEs) as a 
result of taking medication (DeWalt, 2010; Institutes of Medicine, 1999).  Overall, 
medication interactions have been found to be the main cause of ADEs.  Although 
legislation exists that provides guidance for accurate and easy-to-read labeling for 
medication, ADEs due to medication still occur (United States Food and Drug 
Administration, 2009). Furthermore, older adults or individuals 65 years and older are 
potentially at higher risk of ADEs due to several factors. Unlike prescription medication, 
OTC medication can be purchased at will by a consumer and requires the consumer to 
facilitate the process of determining if the medication is appropriate given their health 
history (DeWalt, 2010; Institutes of Medicine, 1999).  Older adults account for nearly 
40% of all OTC medication use, use twice as many OTC medications compared to 
prescription medications and on average, take between 6 and 9 medications concurrently 
(Conn, 1992; Glaser and Rolita, 2009; Rolita and Freedman, 2008 ).  Older adults are 
also at higher risk for chronic illness, placing them at increased risk of drug-disease 
interactions.  Older adults also tend to have lower health literacy levels compared to other 
age groups meaning that older adults may find it more challenging to “understand and act 
upon health information” (Nielsen-Bohlm, 2004).  Therefore, OTC consumer decision-
making can become daunting and complex task for older adults (Martin, Jones, and 
Gilbert, 2013; Neafsey, Strickler, Shellman and Chartier, 2002).  This research therefore 
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focused on evaluating the effectiveness and feasibility of translator designed for older 
adults that aims to reduce the difficulty of OTC medication information. 
 
Challenges to Communicating Medication Information 
Currently, the primary information source for OTC medication information is the 
OTC medication label or Drug Fact Label (United States Food and Drug Administration, 
2009).  The purpose of the label is to orchestrate a complex set of behaviors by the 
consumer (Brass and Weintraub, 2003).  Most consumers who decide to read the label 
use only the label to make his or her decision and many do not read the label at all (Brass 
and Weintraub, 2003; Covington, 2006).   Several studies have identified barriers to 
communicating OTC medication information through a print medium and have suggested 
improvements for making medication information more useful and useable by different 
populations (Brass and Weintraub, 2003; Klein and Issacson, 2003; Morrow, Weiner, 
Young, Steinley, and Murray, 2003; Sansgiry, Bix, Clarke., and Pawaskar,2005).  
However, print mediums still have limitations.  Some researchers believe that technology 
may be a potential medium for addressing some of the limitations of print-based text 
(Healthy People 2020; Gibbons et al, 2009). 
Consumer Health Informatics (CHI) is an area of public health that is concerned 
with how to communicate health information to consumers through technological means 
(Gibbons et al, 2009).  CHI researchers attempt to “analyze” consumers’ need for 
information; and study and implement methods for making information usable to 
consumers (Eysenbach, 2000).  A review of CHI literature shows that CHI applications, 
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in particular those that include tailoring, personalization, and/or behavioral feedback 
contribute to favorable health outcomes (Gibbons et al, 2009). Both tailoring and 
personalization involve building customized interventions based on knowledge of an 
individual’s or group’s characteristics (Gibbons et al, 2009).  This research focuses on 
evaluating a tailored intervention designed for older adults through a human-centered 
design process.  Data gathered from prior studies informed the design of the first version 
of the translator that is used in this study.  Additional opportunities for reducing the 
difficulty of OTC medication for older adults will be identified in this study and 
integrated into forthcoming versions of the translator. 
 
Human-Centered Text Simplification 
Simplifying text is a one way to reduce the complexity of text.  Government 
advocacy groups have emphasized the importance of the role of simplified text for 
helping consumers better understand health information (Center for Plain Language, 
2012; PlainLanguage.gov, 2012; U.S. Department of Health and Human Services, 2012).  
The Plain Language Act of 2010 requires federal agencies to use “clear Government 
communication that the public can understand and use” (U.S. Congressional Committee 
of Oversight and Government Reform, 2010).  PlainLanguage.gov was created to provide 
guidelines to the public on how to comply with the law (PlainLanguage.gov, 2012). 
 
Similarly, in Natural Language Processing, researchers have created techniques 
for simplifying health information automatically using various translators.  This 
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approach, known as text simplification, takes a sentence in a document, runs it through 
the technique, identifies “difficult terms”, and systematically replaces the terms with 
synonyms and/or explanations until the sentence has been simplified (Siddharthan, 2004).  
This process is repeated until all sentences in the document have been simplified (See 
Figure 4-1).  Difficult terms and the level of simplicity needed is often defined by the 
designer and often evaluated through readability testing (Kandula, Curtis, and Zeng-
Treitler, 2010; Boyce, Hrakema, and Conway; 2010; Elhadad, 2006).  Few studies, 
evaluate the technique directly with users.  This study examines the effectiveness of a 
prototype translator designed for simplifying OTC medication information directly with 
older adults users. 
 
 





This study examines the feasibility and effectiveness of a prototype translator 
designed to assist older adults with over-the-counter medication information.  The 
translator was designed through a human-centered process in which information needs 
were gathered and later included in a prototype to elicit additional feedback from 
participants.  The results of prior studies were used to inform the design of the translator 
being examined in the proposed study.   
Due to the limited resources available to support automated text simplification of 
health information, few studies exist that focus on designing and evaluating such 
techniques.  This study is innovative because no study has examined how to design a 
translator for simplifying over-the-counter medication information automatically. In 
addition, most studies that focus on automatic text simplification of health information do 
not evaluate the effectiveness of the technique directly with the targeted user group.  
Instead, most studies use readability testing (e.g. Flesch Kincaid, SMOG) to evaluate the 
effectiveness of the technique for simplifying health information (Kandula, Curtis, and 
Zeng-Treitler, 2010; Boyce, Hrakema, and Conway; 2010; Elhadad, 2006).  Although 
readability tests provide a indirect measure of how simple the information is, the 
proposed study aims to understand if the technique impacts users intention to use the 
medication information in the decision making process and also older adults 
comprehension of the medication information.  This study, therefore, aims to advance 
previous research in this area by examining the effectiveness of the technique directly 
with users from the target population as opposed to indirect measures.  The goal is to 
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better understand the effect of the translator on intention of older adults to use the OTC 
medication information in their decision-making process and also to gain feedback on 
how to improve future iterations of the technique. 
 
THEORY OF PLANNED BEHAVIOR (TPB) 
TPB definition and background 
The theory of planned behavior has been used widely in healthcare studies that 
focus on human action (Ajzen, 1991, 2002, 2013).  In TPB, it is believed that human 
behavior is guided by three types of beliefs: behavioral, normative, and control (See 
Figure 4-2).  Behavioral beliefs are “beliefs about the likely outcomes of the behavior and 
the evaluation of these outcomes” (Ajzen, 1991, 2002, 2013).  Normative beliefs are 
“beliefs about the normative expectations of others and motivation to comply with these 
expectations” (Ajzen, 1991, 2002, 2013).  Control beliefs are the “beliefs about the 
presences of factors that may facilitate or impede performance of the behaviors and the 
perceived power of these factors” (Ajzen, 1991, 2002, 2013).  These beliefs help to form 
a behavior intention.  According to the theory, an individual’s intention to perform some 
behavior is indirectly influenced by one or more of the three beliefs.  In addition, if given 
enough actual control over a behavior an individual is expected to carry out the behavior 
(Ajzen, 1991, 2002, 2013).  Interventions that aim to change behavior should therefore 
address one or more of the three factors.  In other words, interventions that persuade 
humans to change behaviors should focus on changing individual normative, behavioral, 
and/or control beliefs.   However, when choosing which factor(s) to address, it is 
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important to consider the potential degree of change that can be made in the area being 
targeted.  Therefore, formative research can be a very important step on choosing which 




Figure 4-2.  Theory of Planned Behavior (Ajzen, 1991, 2002, 2013) 
  
Why TPB? 
The TPB is one of many theories about human behaviors, but is thought to be one 
that is more suited for studies involving communication and media (e.g. computer-based 
interventions) (Finnegan and Viswanath, 2008).  When humans communicate, they 
produce and exchange information using symbols and signs and communication is 
thought to be a central tenant of understanding human behavior (Finnegan and 
Viswanath, 2008).  For studies examining the impact of media exposure on individual 
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behavior, several theories have been used.  However, expectancy value theories such as 
the TPB are more often used and found to offer explanation for media effects on behavior 
at the individual level.    
In this study, the effect of the prototype translator (the media) on the control 
beliefs (perceived difficulty and perceived controllability) of older adults will be 
examined (Finnegan and Viswanath, 2008).  According to the TPB theory, control beliefs 
are often measured by a perceived control component.  Although there is some guidance 
provided for measuring perceived control, no single measure exists (Kraft, 2005).  For the 
purposes of this study, two measures will be used: perceived difficulty (self-efficacy) and 
perceived control (controllability).  Perceived difficulty is defined as a “person’s belief as 
to how easy or difficult performance of the behavior is likely to be” (Ajzen, 1991, 2002, 
2013).  Perceived control is defined as “the extent to which a person perceives the 
behavior to be under their control” (Ajzen, 1991, 2002, 2013).  These components 
together were used to measure older adults control beliefs about the difficulty of the OTC 
medication information presented to them with and without the translator. 
In a previous study, the difficulty of medical terms on OTC medication labels, 
were found to be a barrier to communicating OTC medication information to older adults 
(Martin, Jones, and Gilbert, 2013).  In other words, the older adults interviewed found it 
difficult to understand some of the medical terms that appeared on the OTC medication 
label.  A translator was developed to improve the difficulty of the medical terms and 
provide older adults with more control over the task of using the label information to 
decide whether or not an OTC medication is appropriate.  Therefore, the OTC medication 
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information simplified by prototype translator is expected to support more favorable 
control beliefs and thereby increase older adults intention to use the label information for 




This study is part of larger Exploratory-Sequential Mixed-Method study on the 
use of technology to assist older adults in the OTC decision-making process (Creswell, 
2013). Prior to this study, a preliminary study was conducted that focused on the design 
of the OTC medication translator being evaluated in this study.  Information retrieval 
approaches were identified for providing synonyms and explanations of complex medical 
terms appearing on OTC medication labels.  The synonyms and explanations were first 
identified using a manual search method.  The manual search method was informed by 
results of previous studies that suggested that older adults may have trouble 
understanding certain terms on the OTC medication label (e.g. chronic illnesses, 
medication names) (Martin, Jones & Gilbert, 2013).   
 
Building the Controlled Vocabulary 
One limitation of providing automatic text simplification for health information is 
that there are limited data sources (e.g. corpora, dictionaries, controlled vocabularies) that 
exclusively support automatic translation from medical terminology to consumer health 
terminology (Zeng & Tse, 2005).  Therefore, one of the first steps in designing an 
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automatic simplification technique was to identify data sources that could support the 
translation from medical terminology to consumer health terminology.  Because, the 
purpose of the translator is to provide decision support, it was important that any data 
source that was used be validated.  As mentioned before, many resources for automatic 
text simplification that are available do not exclusively support translation of medical 
information.  Further, many do not provide support for the translation of medical terms. 
One of the few resources that showed promise was an effort by Zeng and Tse (2005) to 
create an open-source consumer health vocabulary.  However, after examining the 
feasibility for this experiment, many of the terms that were identified were not yet 
included in the database.  Therefore, although this effort shows a move toward supporting 
automated simplification of health text; it was not yet sufficient for use in this 
experiment. 
Because, an existing data source could not be identified, the researchers instead 
created a controlled vocabulary from a validated paper-based resource.  The Plain 
Language Thesaurus for Health Communications published by the National Center for 
Health Marketing, The Department of Health and Human Services, and the Centers for 
Disease Control is a validated resource that provides plain language equivalents to 
medical terms, phrases, and references (National Center for Health Marketing, 
Department of Health and Human Services, and the Centers for Disease Control, 2007).  
However, to date, the thesaurus only exists in paper-based form.  For the purpose of the 
experiment, the researchers created a script that parsed the document to create a digital 
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version of the thesaurus.  This served as the basis for the controlled vocabulary used to 
support the tool. 
Fifty medications were chosen randomly from the Food and Drug Administration 
(FDA) Drug Database and were used as a training set.  The FDA Drug Database uses 
Structured Product Label Format (a type of XML).  Medication manufacturers use SPL to 
create labels that comply with FDA requirements use this format.    Currently there is no 
Application Programming Interface (API) for accessing medication label information.  
Therefore, the raw data files for Human OTC Medications were downloaded and used as 
the overall data set for creating the technique.  At the time of download there were 22,698 
Human OTC Medications in the dataset.  This data set included all OTC medications 
including pain medication, allergy medication, and cough syrup, but also lotions, hand 
sanitizers, and medicated lip balm.  Therefore, the researcher chose randomly from the 
set, selecting only medication that could be administered through ingestion (e.g. liquids 
and tablets) until the training set included 50 medications. 
To supplement the terms included in the Plain Language Thesaurus, the terms 
included in the 50 medications in the training set were analyzed manually for potential 
inclusion as a difficult term. In doing so, the researcher focused on identifying medical 
conditions, chronic illnesses, and medication names/types because these were identified 
in a previous study as being difficult to understand.    Two hundred unique difficult terms 
were identified in the first round of manual analysis of the 50 medications.  Terms were 
compared with the terms in the Plain Language Thesaurus to determine if it could 
sufficiently provide mappings to consumer-based terms.  From this round of analysis, it 
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was determined that although the Plain Language Thesaurus provided support for many 
of the condition names, however many of the medications that had been identified as 
difficult terms were not currently present in the database.  Therefore, Medline Plus 
Health Topics was used to provide definitions for the terms not included in the database. 
Mediline Plus is a validated course of consumer-based health information.  It 
provides and API and a search tool for retrieving information about health terms.  Forty-
six additional terms were added to the database using Medline Plus.  Terms in this group 
appeared 388 times over all 50 documents.  Definitions for the 46 additional terms were 
generated using Medline Plus based on a “is a” rule meaning that the text following 
TERM “is a” was used as the consumer health explanation equivalent.  In total, the 
controlled vocabulary created for this experiment includes 2689 terms with 
corresponding consumer-based definitions.  The vocabulary served as a database for the 
translator for simplifying terms identified as difficult medical terms.  
 
The Prototype Translator 
The prototype translator implemented for this study borrows from the idea of text-
simplification (See Figure 1).  In simplest form, the process of text-simplification, lexical 
simplification, involves mapping and replacing more complex terms to simpler terms or 
phrases.  While this may seem trivial, one of the major hurdles of this approach is finding 
a dictionary to provide these one-to-one mappings (Zeng & Tse, 2005).  Syntactic 
simplification is the process of automatically restructuring complex sentences into 
simpler sentences.  When considering the idea of replacing terms with phrases or 
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restructuring sentences, the syntactic structure of the sentence must also be considered 
since the goal of text simplification is to make the text simpler while preserving the 
meaning of the sentence (Damay, Lojico, Lu, Tarantan, & Ong, 2006).  
The translator used for this project borrows from lexical simplification by 
providing mappings from complex terms to their consumer-based equivalents (terms or 
phrases).  Lexical simplification was chosen as a first step because one goal of this study 
was to determine additional ways to deliver the health information to user. In addition, 
lexical simplification has been one to approach that researchers employ for simplifying 
health text (Leroy, Endicott, Kauchak, Mouradi, and Just, 2013; Leroy, Endicott, 
Mouradi, Kauchak and Just, 2012; Kandula, Curtis, and Zeng-Treitler, 2010).  The 
translator that was created was therefore designed to provide a 1-1 mapping to terms and 
phrases provided in the controlled vocabulary.   
The translator retrieves text from a database of medications, parses the text to 
identify difficult terms, and provides simplified terms or explanations to the user in the 
form of an alternative consumer-based term or phrase (See Figure 4-3).  Difficult terms 
were defined as any term appearing in the controlled vocabulary.  The controlled 
vocabulary included single terms such as “diabetes” and compound terms such as “bowel 
movement”.  Because some terms appeared both as a single term and as part of a 
compound term (e.g. “allergic” and “allergic reaction”) in the controlled vocabulary, 
when parsing the original medication text, the parser used a sliding window approach to 
identify compound medical terms.  In addition, before comparing terms found in the 
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medication text with terms in the controlled vocabulary, punctuation was removed to 
increase the hit rate for matches.   
 
Figure 4-3.  Translator Design 
 
The original text was parsed at run-time and was modified to include interactivity 
that provides alternative consumer-based term or phrase.  This approach was taken in lieu 
of replacement for two reasons.  First, because of the nature of the domain being studied, 
it was important not to alter the text in any way that would change the meaning of the 
text.  Second, for lexical simplification where there is a 1-1 match of terms the challenge 
of restructuring sentences is minimized.  However, when replacing terms with phrases, 
one must consider if the sentence makes sense or if it needs restructuring.  In the past, 
researchers have addressed this through a manual review of the text after the 
simplification has been completed (Leroy, Endicott, Mouradi, Kauchak and Just, 2012; 
Kandula, Curtis and Zeng-Treitler, 2010).  However, one of the design goals for this 
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translator is that it is flexible enough to be used in a system “in the wild” where manual 
review of the text after simplification would be cumbersome and inconvenient.  
Supplementing or augmenting the original text with simplified alternative is another 
approach that removes the need for manual review and several researchers have found 
this approach to be useful in lieu of full replacement of the text (Wilcox, Morris, Tan, 
Gatewood, and Horvitz, 2011; Leroy, Endicott, Kauchak, Mouradi, and Just, 2013).  
 
Testing the Translator 
During training, the translator was designed to successfully replace the 246 
difficult terms identified in the manual review of the medication documents.  After 
implementation, the translator was tested using another set of 50 medications chosen at 
random from the FDA Human OTC Medication data set.  Medications included in the 
training set were excluded from the selection process.  Similar to the training set, 
medications were chosen at random from the entire set of Human OTC medications.  If 
the medication met the requirements for inclusion, it was added to the test set.  This 
process continued until there were 50 medications in the test set.  The 50 medication 
documents selected for the test set were scrubbed and included in a test database.  This 
database served as the data source for the translator. 
Over the 50 documents included in the data set, 1357 1-1 matches were made, 
1002 unique 1-1 matches were made, 536 near-match words were identified, and 368 
unique near-match words were identified by the translator (See Table 4-1).  On average, 
27 1-1 matches were made per document, 20 unique 1-1 matches, 11 near-matches, and 7 
 90 
unique near-matches were made per document.  A porter stem algorithm was included in 
the translator to remove (“stem”) word endings and find near-match terms in the 
controlled vocabulary. 
 1-1 Match Words 
Identified 







Total Over All 
Documents 




7 - 53 7 - 40 2 - 25 2 - 14 
Average Per 
Document 
27 20 11 7 
 
Table 4-1.  Results of Translator Testing 
Prototype Interface 
An interface was designed to facilitate an experiment to better understand the 
effect of the translator on perceived and actual difficulty of older adults’ understanding of 
over-the-counter medication information.  The interface was designed to display warning 
information for four medications (See Figure 4-4).  Medication information was queried 
from the medication database and depending on whether the flag for the translator was 
set, the interface presented information with or without the text translated.  Therefore 
each of the four medications had a translated and non-translated version. 
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Figure 4-4.  Screenshot of Interface Utilizing Translator 
 
The four medications presented in the prototype included a medication for upset 
stomach, a cold medicine, an allergy medication, and a pain reliever.  These medications 
were purposely chosen to provide variety and representation of the most widely used oral 
over-the-counter medications.  Apart from these categories, medication texts were chosen 
to meet the criteria that each was approximately the same reading level.  An 8th grade 
reading level was chosen since it is the average reading level in the United States (See 
Table 4-2).  All documents had an approximate grade reading-level of 7th-8th grade and a 
reading ease score of approximately 60, which suggests the documents, should be easy to 





 Medication 1 Medication 2 Medication 3 Medication 4 
Word Count 261 213 395 200 
Unique Word 
Count 
133 127 189 120 
Flesch-Kincaid 
Reading Ease 
61.5 59.8 57.7 59.7 
Flesch-Kincaid 
Grade Level 
7.2 7.9 7.9 7.3 
 
Table 4-2. Description of Medication Texts 
Research Questions 
To better understand the impact of the translator on perceived and actual 
difficulty, and user satisfaction the following research questions were examined. 
 
Research Question 1: Does the medication information simplified by the translator 
generate more positive control beliefs among participants compared to medication 
information not simplified by the translator? 
a. Do older adults perceive the information to be less difficult when presented with 
the translator compared to information not simplified by the technique? 
b. Are older adults more confident when presented with information simplified by 
the translator to identify risks and benefits of an OTC medication? 
c. Do older adults believe they have more control of identifying risks and benefits of 
OTC medication when presented with information simplified by the translator? 
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Research Question 2: Is information simplified using the translator more effective at 
communicating OTC medication risks and benefits compared to information that is not 
simplified? 
a. Is the number of participant errors reduced when using the translator? 
 
Research Question 3:  Does the translator increase task completion time? 
 
Research Question 4: Were participants more satisfied using the simplified information 
compared to the non-simplified information? 
a. Did participants prefer using the simplified information compared to the 
non-simplified information? 
b. Did participants find the simplified information more helpful compared to 
the non-simplified information? 
 
METHODS 
Participants and Study Location 
This study is focused on improving OTC medication communication for those 65 
years and older.  In addition, the focus of this study is to improve communication for 
older adults in the process of deciding appropriate OTC medication given their prior 
health history.  Participants of the study were therefore be required to be 65 years of age 
or older and have experience purchasing or selecting their own OTC medication in the 
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past year.  The study was be conducted at two organizations within the local community 
that cater to those older than 50. 
Older adults were recruited through purposeful sampling from two organizations 
within the local community. The lead researcher met with directors of the two 
organizations to discuss the details of the study, what the study is about, and the 
requirements for volunteering.  The directors of the organization made first contact with 
potential participants through email, flyers, or verbal announcement of the study.  
Participants were asked to contact the lead researcher if they were interested in 
volunteering for the study.  Older adults were paid $15 for their participation. 
Twenty-one older adults volunteered for the study. Approximately 62% of the 
participants were female (N=13) and all but three participants were retired (N=18).  
Eighteen participants were Caucasian and 3 were African-American.  All participants 
selected English as their primary language.  Participants’ ages ranged from 64 – 90 (mean 
~ 73 years, SD ~ 8 years).  All participants were familiar with purchasing or taking over-
the-counter medication. 
Because the experiment was conducted using a computer, data was collected on 
participant’s past use of computers and computational devices.  All but 3 participants (N 
= 18) used a laptop or desktop computer at least 3 or more times a week.  Nine 
participants used a smart phone or tablet device at least 5 or more times a week.  Only 
two participants did not use a computer, smart phone, or tablet device weekly.  Nineteen 
participants indicated that they used the Internet weekly.  Eleven participants indicated 
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that they used the Internet to search for information about prescription medication, while 
only six used the Internet to search for information about over-the-counter medication. 
 
Data collection methods 
Institutional Review Board (IRB) approval was obtained before data was 
collected.  Each older adult participated in an experiment that examines the impact of the 
translator on the perceived and actual difficulty of the OTC medication information.  
Before the participant began, the participant was asked to complete a demographic and 
computer use survey.  This data was collected to 1) ensure the participant met the 
participation requirements and 2) examine the impact of the participants experience with 
using computers and using computers to search for medication information on the 
proposed study.  In addition, participants were asked to complete a verbal health literacy 
test – REALM (Health Literacy Measurement Tools: Fact Sheet, 2009) to gauge how 
well the participant may be able to “understand and act upon health information” 
(National Center for Education Statistics, 2003).  Participants in the study had on average 
a REALM score of approximately 6 (SD ~ 2).  However, eighteen of the participants had 
a REALM score of 7, which is the highest score possible on the REALM test, meaning 
that the group of older adults participating in this study should not have much trouble 
understanding and acting upon health information. 
After completing the REALM test, participants were presented with a 
demonstration of how to use the translator.  The information presented in the demo was 
not related to medication but presented a short paragraph about a storybook character.  
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The participant was allowed to get acquainted with how to use the translator and was told 
that they may see similar options in the experiment. Each participant received 4 different 
treatments (medications) during the experiment (See Table 4-3). Counterbalancing of 
treatments between participants was used to reduce carryover effects due to practice or 
fatigue.  Medications were grouped based on the similarity of their grade level score so 
that each participant received one simplified and one non-simplified version of each 
medication at that approximate level.  However, each text was different within each 
group to reduce learning effects.  The order in which participants received the treatments 
was alternated for each participant.  The dataset therefore included a total of 84 
observations from the 21 participants.  
 Method of Delivery (W) 
Translated Not Translated 
Grade Level of Text 
(W) 
7.2 & 7.3 N = 21 N = 21 
7.9 & 7.9 N = 21 N = 21 
Table 4-3. Experiment Design 
 
Figure 4-5. Data Collection Process for Each Participant 
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After being presented with the medication information, the participant was asked 
to rate the difficulty, self-efficacy, and their perceived control of the medication 
information on a 7-point likert scale (Kraft, 2005).  The questions mapped directly to the 
research questions and provided insight on the participants perceived control beliefs 
regarding the medication information presented to them.    Each participant was also 
asked several comprehension questions that were designed using the Food and Drug 
Administration Comprehension Testing Guide (U.S. Department of Health and Human 
Services Food and Drug Administration Center for Drug Evaluation and Research, 2010).  
A Likert-Scale item along with the comprehension questions was used to measure the 
actual difficulty of the OTC medication information presented to the participant.  Finally, 
for each medication, the participant was asked to identify any additional issues they 
encountered with the OTC medication information.  At the end of the experiment, the 
participant was also asked to revisit the types of information (simplified vs. non-
simplified) used in the experiment and identify which type of information they preferred 




During the experiment, the researcher also recorded whether or not the participant 
made use of supplemental materials provided to help them answer comprehension 
questions.  Time to complete comprehension questions was also recorded.  Task 
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completion time was recorded as the time interval beginning when the participant began 
answering comprehension question until the participant completed the comprehension 
questions.  A structured coding form was used to record observational data for each task 
in the experiment (Robson, 2011).  This information was used to provide additional 





Self-Efficacy is a person’s confidence that they can perform a behavior if they 
wanted to do so (Ajzen, 2002).  Self-Efficacy was measured using the 7-point Likert-
Item, “Finding risks and warnings using this information would be …”, anchored by very 
difficult/very easy.  For analysis, participants’ ratings were grouped in categories of 
positive (ratings of 5, 6, or 7) and negative (1, 2, or 3).  A rating of 4 was considered 
neutral.  Fifty-nine percent of observations were positive for the simplified information 
compared to 47% for the non-simplified information. To understand the impact of the 
translator on perceived self-efficacy, the proportion of observations in which ratings 
changed from positive to negative (or vice versa) across treatment was analyzed. Forty-
two paired observations were included in the data set.  The McNemar’s test for changes is 
a nonparametric analysis that can be was used test for differences in proportions when 
analyzing nominal, paired data.  Thirty-one observations showed no change across 
treatment groups.  Nine observations moved from negative when participants were 
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presented with non-simplified information to positive when presented with simplified 
information.  Two observations moved from negative when presented with the 
experiment to positive when presented with the simplified information.  The results of 
McNemar’s provide sufficient evidence (df=1, N = 42) that participants’ beliefs about 
self-efficacy differed significantly between the two treatments (P ~ .0348).  Participants 
were more likely to report positive beliefs about self-efficacy when presented with the 
simplified text compared to the non-simplified text. 
 
 
Table 4-4. Contingency Table for Self-Efficacy Ratings 
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Figure 4-6. Result of McNemar’s Test 
 
Perceived Control 
Perceived Control is a person’s beliefs about how much control they have over 
the targeted behavior (Ajzen, 2002).  Perceived Control was measured using the 7-point 
Likert-Item, “If I wanted to, I could find risks and warnings using this information”, 
anchored by strongly disagree/strongly agree.  For analysis, participants’ ratings were 
grouped in categories of positive (ratings of 5, 6, or 7) and negative (1, 2, or 3).  A rating 
of 4 was considered neutral.  Eighty-five observations had positive responses for both the 
simplified and non-simplified versions of the text. To understand the impact of the tool 
on perceived control, the proportion of observations in which ratings changed from 
positive to negative (or vice versa) across treatment was analyzed. Forty-one paired 
observations were included in the data set.  The McNemar’s test for changes was used to 
test for differences in the percentages. Twenty-nine observations showed no change 
across treatments.  Six observations showed a change from positive to negative and 
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negative to positive.  Results of McNemar’s test do not provide sufficient evidence (df=1, 
N = 41) that participants’ beliefs about control differed significantly between the two 
treatments (P ~ 1).  
 
Table 4-5. Contingency Table for Perceived Control Ratings 
 




Perceived Difficulty vs. Actual Difficulty 
Perceived and Actual Difficulty was measured using a 7-point Likert-Item, 
anchored by strongly disagree/strongly agree.  For analysis, participants’ ratings were 
grouped into categories of positive (ratings of 5, 6, or 7) and negative (1, 2, or 3).  A 
rating of 4 was considered neutral.  Fifty percent of responses about perceived difficulty 
were positive when interacting with the simplified information compared to 38% of 
responses for the non-simplified information.  Further, when examining whether the 
simplified information had any effect on actual difficulty, there was a significant 
improvement in the proportion of participant whose ratings improved from negative 
beliefs about difficulty to positive beliefs about difficulty when interacting with the 
simplified information (W = -87.5, P ~ 0.0049).  However, a similar trend was observed 
for the non-simplified information. 
 
 




Comprehension was measured using a 3-item questionnaire.  The number of 
participant errors included questions the participant answered incorrectly or questions for 
which the participant did not know the answer.  For both treatments, participants made 34 
errors.  Therefore, number of errors did not differ across treatments.  To validate there 
was no difference, the Wilcoxon Signed Rank Test was used to test for difference.  
Results suggest there is not sufficient evidence to support that there was a significant 
effect of treatment (W = -1.5, P ~ 0.5393) for reducing participant errors. 
 
 
Figure 4-9. Results of Wilcoxon Rank Test 
 
Task Completion Time 
Task completion time was recorded on an observational coding sheet and was 
defined as the interval between the participant completing the Pre-Survey questions and 
completing the last question of the Comprehension questionnaire.  Task completion time 
was recorded for each of the four tasks the participant completed throughout the study.  
The average task completion time for participants when using the simplified information 
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was 3 mins/8 secs (185.03 secs).  The average task completion time for participants when 
using the non-simplified information was slightly higher at 3 mins/19 secs, an increase of 
11 secs.  The Wilcoxon Signed Rank Test was used to test for differences between 
groups.  Results suggest that there is not sufficient evidence (W = 5.5, P ~ 0.4721) to 
support that there was a significant effect of treatment for increasing or decreasing task 
completion time. 
 
Figure 4-10.  Result of Wilcoxon Rank Test 
 
Observational Data 
When asked to comment on difficulties or how the information could be 
improved, participant responses varied widely.  Many participants felt that the 
information was well organized, easy to navigate and thorough.  However, others 
commented that they felt that formatting including spacing, font size, and organization 
could be improved.  In addition, several participants commented on the amount of 
information, some felt that some of the information was unnecessary and others felt that 
there was too much information crowded into the Warnings section. 
Concerning the technique, most participants commented on terms such, as 
“salicylates” that were not translated that they felt should be. This was consistent with the 
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observational data collected for the number of times support materials were used.  
Between the control and the experiment, participants used support materials 33 times 
suggesting that some information was not readily clear and/or missing from the 
information provided by the prototype.  Three participants commented that they felt that 
having certain words highlighted made the information easier to read, made it easier to 
focus, and helped to organize the information.  One participant felt that the simplified 
terms were not helpful in their current form. 
 
User Satisfaction 
Two open-ended questions were used to measure user-satisfaction.  Participants 
were asked to discuss which version of the information (simplified vs. non-simplified) 
they preferred using and which version of the information they found more helpful.  
Participant’s responses to these questions were coded to fit in one of three categories 1) 
Experiment (simplified version) 2) Control (non-simplified version) or 3) Neutral (no 
strong preference).  Nineteen participants responded to both questions and 2 participants 
did not provide a response to either question.  When asked to discuss which system they 
preferred, 68% of participants expressed that they preferred using the translator, 26% 
were in favor of the non-simplified information, and 6% were neutral.  When asked to 
elaborate on why they preferred the simplified text, nearly all participants commented 
that they liked having the additional information available when and if they needed it.  
One participant stated, “The pop-ups, because it provides additional information in 
laymans terms”.   Comments from the five participants who preferred the non-simplified 
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information were more varied.  One participant felt that not having the tool-tips forces a 
person to focus more on the warnings.  Another felt that the tool-tips were not necessary 
and similar to the previous statement encouraged people to skim the information.  A third 
participant felt that the tool-tips made the information too complicated.  
When asked which version of the information they thought were more helpful, 
participants’ responses were the same as the responses for preference.  Sixty-eight 
percent of participants expressed that they preferred using the translator, 26% were in 
favor of the non-simplified information, and 6% were neutral. When asked why they felt 
the simplified text was more helpful, once again, nearly all responses alluded to having 
simplified information available when needed. Of the 26% that found the non-simplified 
text more helpful, similar to preference, responses were related to the complexity added 
by the tool-tips or as one participant stated, “I found the highlights annoying”.   
To determine if these observed frequencies for satisfaction deviated significantly 
from the expected frequencies a One-Way Chi-Square Classification was conducted (See 
Table 4-6). 
 
Outcomes Observed Expected (Fo – Fe) (Fo – Fe)2 (Fo – Fe)2/ Fe 
Experiment 13 6.33 6.67 44.49 7.03 
Control 5 6.33 -1.33 1.77 .28 
Nuetral 1 6.33 -5.33 28.41 4.49 
 19 19   X2 =11.80 
df = 3 – 1 = 2 
Table 4-6. Result of One-Way Chi Square Test 
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Based on the Chi-Square reference table, a X2 of 5.99 or greater is needed for X2 
to be significant at the .05 level.  Therefore, a result of X2 of 11.80, suggests that there is 
enough evidence to reject the hypothesis that the results of the study could have happened 
by sampling error alone and the deviations between the observed and expected 
frequencies are significant. 
 
DISCUSSION & IMPLICATIONS  
The goal of the study was to evaluate the feasibility and effectiveness of translator 
designed through a human-centered process that simplifies OTC medication information 
for older adults. In its current state, results suggest that the prototype translator evaluated 
shows promise as a method for providing simplified OTC medication information to the 
older adult population.  Participants’ confidence in their ability to complete the task at 
hand improved significantly from negative to positive when provided with OTC 
medication information enhanced by the translator compared to information not 
enhanced.  In addition, a significant proportion of the participants preferred using the 
information enhanced by the technique compared to information not enhanced.  
Similarly, a significant proportion of the participants found using the information 
enhanced by the technique more helpful than information not enhanced by the technique.  
Although, results were not significant, participants provided more positive belief ratings 
of perceived difficulty and the presence of the technique did not increase task completion 
time. 
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In addition, the study provides interesting insights on the feasibility of the 
technique. With further improvement the technique may be a feasible option for 
delivering simplified OTC medication information to users. Because of the number of 
participants’ comments on formatting, coupling the technique with good information 
presentation and design practices may improve the overall effectiveness of the translator 
while further assisting participants with the task at hand.  Participants’ comments also 
reveal that some of the terms that were simplified did not need to be and others that were 
not simplified should have been.  From a technical standpoint, validated data sources to 
support the tool are limited however research in this area is growing and several 
promising resources exist. The Plain Language Thesaurus for Health Communications 
provided a good starting point for building a controlled vocabulary for this study.  
However, based on participants’ comments, more research is needed to better understand 
how and when terms should be translated in the context of supporting OTC medication 
understanding.  Additionally, although the controlled vocabulary supported simplified 
versions of several terms, there were terms that were not covered.  Therefore, continued 
research on creating data sources for consumer-based text simplification of health 
information is needed.   In particular, for this study, consumer-based explanations of 
many of the medications and ingredients identified in this study were not covered in the 
thesaurus and a good validated data source was not found elsewhere. 
To summarize, the goal of this study was to examine the feasibility and 
effectiveness of a technique for delivering simplified OTC medication to older adults.  
Because there is limited research that examines that specific challenge of delivering 
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simplified OTC health information to older adults, this study also provides a basis to 
guide future studies. The technique evaluated in this study had a positive impact on 
participants’ confidence in completing the task at hand.  In addition, participants 
preferred using the technique and found the technique more helpful than not using the 
technique.  Results suggest that with more research and further improvement, the 
technique is a feasible option for providing simplified OTC medication information to 
older adults.  Additionally, the technique may increase user confidence and be a preferred 
and helpful tool for navigating OTC medication information. 
 
LIMITATIONS 
Participants in the study were purposefully recruited and although participants 
ranged in age, education level, and familiarity with OTC medications, most participants 
had very high health-literacy levels.  This may have impacted the study results as at this 
level, participants are expected to easily understand and act upon health information.  
Although, participants’ responses were varied, results may not be generalizable to a 
group of participants with more varied health literacy levels.  Therefore, in the future, a 
different recruitment method will be employed to ensure that the sample includes 
participants with more diverse health-literacy levels.  In addition, in the future more 
participants will be needed to detect significance differences at the .05 level based on the 
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CONCLUSIONS & FUTURE WORK 
 
The outcomes of this research have potential implications in several fields 
including human-computer interaction (HCI), public health, consumer health informatics 
(CHI), and information retrieval (IR).  Specifically, the contributions of this research are 
to: 
1. Better understand older adults current over-the-counter medication selection 
practices and challenges and identify opportunities for technology to assist older 
adults in the OTC medication selection process.   
2. Conceptualize and design a novel interface for assisting older adults with OTC 
medication information and examine the usability of the novel interface for 
assisting older adults with over-the-counter medication information in order to 
identify aspects of the design and technology features that are useful and not 
useful for assisting older adults with over-the-counter medication. 
3. Design a prototype translator that delivers simplified OTC medication 
information to older adults and examine the effectiveness of the prototype 
translator for affecting older adults control beliefs, comprehension, and 
satisfaction of OTC medication information.   
4. Provide recommendations for improving future version of the translator and 
similar techniques as well as suggestions for using such techniques in consumer-
based technology that assist older adults with OTC medication. 
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Obtaining user-feedback early and including users throughout the process are 
cornerstones of HCI and UCD research.  The design process and design 
recommendations resulting from this work will help to further inform the design of 
technology to address gaps in health-related communication, especially in older users.  In 
addition, this research highlights design considerations specific to older adults for 
increasing the usability and effectiveness of technologies to communicate health 
information.  Similarly, this research also contributes to the field of consumer health 
informatics.  The design process and artifacts produced from this research will highlight 
ways in which technology design can be used to better and more effectively inform older 
adults of OTC medication risks and more generally, to address gaps in communicating 
consumer health information. Finally, the results obtained from examining the prototype 
translator designed and examined in this research provide insight on the feasibility and 
usefulness of this and similar approaches in helping older adults understand OTC 
medication information.  This research suggests various ways in which these approaches 
can be leveraged or improved to increase the usability CHI applications. 
Although results from studies described in this dissertation provide several 
contributions to various fields, because of the limited research in the specific area of 
focus, much of the work in this dissertation was formative or exploratory. Therefore, 
there are several opportunities to expand on the research presented in this dissertation.  
Aspects of the prototype design and technology features that older adults find useful for 
OTC medication selection were identified through a preliminary evaluation of the novel 
prototype interface designed in this dissertation.  In the future, further development and 
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evaluation of the interface designed would be beneficial to further understand the impact 
of the technology features on older adults short-term and long-term understanding of 
OTC medication information.  In addition, long-term evaluation of a functional prototype 
may help researchers to further understand design requirements and the impact of the 
technology for decreasing adverse drug events due to OTC medication among older 
adults. 
Evaluation of the prototype translator suggests that providing automatic 
simplification of OTC medication information may affect older adults confidence in their 
ability to navigate OTC medication information.  In addition, older adults prefer using 
information that provide support for simplified information and finds this information 
more helpful.  However, results also present several opportunities for future work.  In 
particular, many of the older adults who volunteered in this study had high health-literacy 
levels.  In the future, it would be beneficial to expand this study using a more purposed 
and stratified sampling strategy, to understand the impact of the translator on older adults 
with more varied health-literacy levels.  In addition, although older adults found the 
translator useful, results suggest that more research is needed to understand how and 
when simplification support should be provided.  For example, which terms need 
simplification (hypertension or silicate), in what way should they be simplified (full 
replacement or augmentation), and what are the tradeoffs (e.g. safety, reading ease).  
Finally, qualitative results from the final study of this dissertation suggest that text 
simplification alone may not be enough to assist older adults with the particular task of 
OTC medication selection.  For example, although participants had high health-literacy 
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scores, the number of errors was high regardless of whether simplification support was 
provided.  Therefore, in the future, additional research that focuses on how to integrate 
simplification techniques with other aspects of design or technology features and the 
effectiveness of those strategies on older adults understanding of OTC would be 
beneficial. 
The major goal of this research was to better understand and abstract design 
recommendations used to inform the design of a novel technological artifact and its 
components that assists older adults in better understanding the risks and benefits of OTC 
medications.   Furthermore, this research aimed to determine the usefulness, usability, 
and short-term effectiveness of that resultant artifact for improving understanding of 
OTC medication risks for older adults.  A three-phase human-centered approach 
including formative research, user-centered design and evaluation was employed to 
understand the design recommendations, produce artifacts, and answer the major research 
questions.  This dissertation describes the motivation for the research question(s) being 
investigated and demonstrates two ways that technology is useful for communicating 
OTC medication information to older adults.  Future work in this area will be beneficial 
to further understanding design requirements for helping older adults navigate the OTC 
medication selection process.  Additional research on the short-term and long-term 
effectiveness of the artifacts produced in this dissertation will be beneficial to further 
understanding the impact of these technologies on older adults understanding of OTC 
medication information.   Similarly, additional research is needed to better understand 
how such technologies can be effectively integrated in the day-to-day lives of healthcare 
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consumers to improve interactions with health information and improve healthcare 

























STUDY I & II PROTOCOL & MATERIALS 
Exploring the Design Requirements for Technology to Help Older Adults Identify 
Potential Over-the-Counter Medication Benefits and Risks 
Session I Protocol 
Script 
[Introductions] 
I appreciate you taking the time to talk with us today. I would like to start by telling you a 
little bit about our study and get your consent to participate. 
[Present Participant with Informed Consent Form and Read Information] 
This study focuses on creating technology to help older adult identify and understand 
potential over-the-counter medication benefits and risks. Today, I would like to interview 
you to learn more about you, your current medication management practices, how you 
currently go about purchasing over-the-counter medications and the challenges you may 
face, and also any technology you currently use or feel may be useful to support you in 
this task.  Before we begin, I would like to ask for your permission to audio record this 
interview.  This is for research purposes only and any identifying information will be 
removed from the data.  
[Wait for Response] 
 Do you have any other questions before we begin? 
Background Information 
1. What is your race/ethnicity? 
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a. Black/African American 
b. White/Caucasian 
c. Asian/Pacific Islander 
d. Indian 
e. Native American 
f. Hispanic 
g. Other: Please Specify  
 
2. What is your gender? 
a. Male 
b. Female 
3. How old are you?  
4. What is your primary language? 
5. What is your highest level of education? 
6. What is your occupation? 
7. Which of the following most accurately represent your current living situation? 
a. House/Apartment/Condominium 
b. Independent Living Community 
c. With Friends or Family 
d. Other: Please Specify 
Medication Management Practices 
1. Do you currently take any medications (e.g. prescription)? 
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2. If so, how many medications do you take on a daily/weekly basis? 
3. Have you taken an over-the-counter medication (non-prescription) medication in 
the last year? 
4. On average, how many over-the-counter medications do you take per 
week/month? 
Current OTC Medication Purchasing and/or Selection Practices 
Think about your experiences selecting and purchasing OTC medications.  I will now ask 
you questions related to purchasing or selecting OTC medications. 
1. Do you purchase your own OTC medications? 
a. If not, who purchases your OTC medications for you? 
b. If so, do you always purchase your own OTC medication? 
i. Who helps you purchase your OTC medications? 
2. Say that you want to take a certain OTC medication for the first time.  Describe 
how you currently go about selecting and/or purchasing an over-the-counter 
medication for the first time. 
a. Do you ask someone for an opinion?  If so, who do you consult. 
b. Do you use the medication label or some other resource to make your 
decision? If so, please describe. 
c. Do you use technology in any way? If so, please describe. 
3. Say that you want to take an OTC medication that you have taken before.  
Describe how you go about selecting and/or purchasing an over-the-counter 
medication that you have purchased before. 
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a. Do you ask someone for an opinion?  If so, who do you consult. 
b. Do you use the medication label or some other resource to make your 
decision? If so, please describe. 
c. Do you use technology in any way? If so, please describe. 
OTC Medication Information Challenges 
1. Thinking back on your OTC medication purchases over the past year, describe 
any challenges, if any, you have had with the information (e.g. OTC medication 
label) used to make your decision. 
2. I will like to now show you examples of OTC medication information and I 
would like for us to discuss anything that you think may be challenging or helpful 
for making a decision on whether this medication is appropriate for you to take. 
• Font-size? 
• Organization? 
• Language used? Where there words that you didn’t know. 
• Can you identify potential risks? 
• Did you understand the information in each section? 
• Is there something you feel that is missing? 
• Were there parts of the label that you found useful or liked about the label? 
Technology Feasibility 
As I mentioned earlier, we are looking at ways to design technology that could assist you 
in understanding and identifying potential over-the-counter medication risks.  We are in 
the process of determining which type of technology may be useful in this task.  
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1. Do you use any of the following on a weekly basis? 
a. Smart Phone 
b. Tablet or Pad 
c. Kiosk 
d. Desktop or Laptop Computer 
e. Other.  Please Specify 
2. What type of tasks do you complete using these technologies? 
3. What are you initial thoughts on potentially using one or more of these to support 
you in making OTC medication-purchasing decisions?  Do you have any 














Verbal Recruitment Script  
Clemson University 
Exploring the Design Requirements for Technology to Help Older Adults Identify 
Potential Over-the-Counter Medication Benefits and Risks. 
 
Hello, I am Aqueasha M. Martin and I would like to look at ways that technology can be 
designed and may be useful in helping older adults identify potential over-the-counter 
drug benefits and risks.  Each year, thousands of people die or are injured due to adverse 
medication interactions.  Over-the-counter drugs contribute to these numbers.  The 
potential risk of adverse over-the-counter drug interactions increase as we age due to the 
natural process of aging and factors such as chronic illness that are prevalent among the 
aging population.  Because of this we would like to look at ways that technology can help 
older adults identify and understand benefits and risks.  Your participation in this study 
will allow us to better understand the process in which older adults participate when 
purchasing over-the-counter medications and the challenges you face, to determine the 
appropriateness of various types of technology for completing the desired task, and/or to 
better understand the what should be included in the design of technology that can assist 
older adults in understanding the benefits and risks associated with over-the-counter 
medications given your personal health history.   
 
The study will require 45 minutes – 4 hours of your time depending on your desired level 
of involvement.  An introductory interview will be conducted and you will then be 
invited back to participate in 1-3 follow-up interview that will help us understand the 
design requirements for our technology.  Each session will require approximately 45 
minutes – 1 hour of your time.  Participation in all parts of the study is voluntary and you 
may withdraw participation at any time.  Please know that I will do everything I can to 
protect your privacy.  Your identity or personal information will not be disclosed in any 
publication that may result from the study. Notes that are taken during the interview will 
be stored in a secure location.   
 









PROTOCOL – SESSION II 
Introduction (10 - 15 minutes) 
 
• Introductions	  
• Explain	  Study	  and	  Get	  Consent	  
• Thanks	  for	  Participating	  
Script 
Investigator (I) Participant (P) 
I:  So, before we begin, I would like to explain a little more about what we will be doing 
today.  First, I will ask some background questions (if do not already have this 
information).  The goal of today’s session is to have you interact with 2 versions of paper 
prototypes (screenshots) and get your feedback on those prototypes.  I will provide you 
with a scenario that you can follow and I will ask you questions after you complete each.  
Basically, we are looking for you to help identify any concerns, things you like, or things 
you don’t like so that we can make this a better project.  Do you have any questions so 
far? 
 
[Ask questions on Background Information Sheet] 
[Give participant first prototype have them walk through]  (30-40 minutes) 
 
Ask questions to elicit feedback on design choices (e.g. colors, font size, layout, 
navigation), and to get a better understanding of the design requirements for technology 
to assist older adults in the task of identifying OTC medication risks.   
 
Potential Topics to Cover Potential Prompts 
Motivation for Use Is this something they would use?  What 
would be the motivation? 
(Alternative mock-ups) 
Ease of Use/Look and Feel Was it easy to use?  Did you understand 
everything?  Did it provide enough info? 
Likes, dislikes, concerns? 
Language Used in the System Issues with terms used? 
Instructions on how to use the System Instructions helpful? 
(Alternative mock-ups) 
Alternative Medication Feature Would you use this feature? Would you 
trust this feature? Amount of information 
provided? 
Recommendation or Information System Which do you prefer? Why? 
(Alternative mock-ups) 
 
If this technology were available, would you use it?  Why or why not? 
Any other comments on how we can improve? 
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Background  Information  –  Session  II  
 
1. What	  is	  your	  race/ethnicity?	  
e. Black/African	  American	  
f. White/Caucasian	  
g. Asian/Pacific	  Islander	  
h. Indian	  
i. Native	  American	  
j. Hispanic	  
k. Other:	  Please	  Specify	  	  
2. What	  is	  your	  gender?	  
a. Male	  
b. Female	  
3. How	  old	  are	  you?	  	  
4. What	  is	  your	  primary	  language?	  
5. What	  is	  your	  highest	  level	  of	  education?	  
a. Some	  K	  –	  12	  
b. High	  school/K-­‐12	  
c. Some	  College	  
d. 4-­‐Year	  College	  
e. Master’s	  
f. Ph.D./Professional	  Degree	  
6. What	  is	  your	  occupation?	  
7. Which	  of	  the	  following	  most	  accurately	  represent	  your	  current	  living	  
situation?	  
a. House/Apartment/Condominium	  
b. Independent	  Living	  Community	  
c. With	  Friends	  or	  Family	  
d. Other:	  Please	  Specify	  
Medication Management Practices 
5. Do	  you	  currently	  take	  any	  medications	  (e.g.	  prescription)?	  
6. If	  so,	  how	  many	  medications	  do	  you	  take	  on	  a	  daily	  basis?	  weekly	  basis?	  
7. Have	  you	  taken	  an	  over-­‐the-­‐counter	  medication	  (non-­‐prescription)	  
medication	  in	  the	  last	  year?	  







STUDY III PROTOCOL & MATERIALS 
Protocol 
 
Hello, my name is Aqueasha Martin.  I am a graduate student at Clemson.  Thanks for 
participating in our study.  Before we begin, I would like to provide you with information 
about the study and get your consent to participate. 
 
[Provide participant with informed consent.] 
 
I will give you time to look over the information and please let me know if you have any 
questions. 
 
[Give participant time to read document and ask questions] 
 
Now that you have looked over the information, would you like to continue? 
 
Before we get started with the experiment, I would like for you to complete a background 
survey and a short exercise that sees how familiar you are with different health terms.  Do 
you have any questions? 
 
[Background Survey & Health Literacy] 
 
Thank you.  Now, let me tell you how the rest of the experiment will go.  On the 
computer, you will be presented with a sample of some over-the-counter medication 
information.  You will then be asked a series of questions about the medication 
information. You will be presented with 3 sets of questions for each of the sample over-
the-counter medication information.  You will receive one set at the beginning (pre-
survey), one set in the middle (comprehension survey), and one set at the end (post-
survey).  Please use the sample over-the-counter medication information to answer the 
questions.  In total you will receive 4 versions of over-the-counter medication 
information At the end of the experiment, I will ask you to complete a short questionnaire 













Thanks for you participation.  
 












































8. What	  is	  your	  race/ethnicity?	  
a. Black/African	  American	  
b. White/Caucasian	  
c. Asian/Pacific	  Islander	  
d. Indian	  
e. Native	  American	  
f. Hispanic	  
g. Other:	  Please	  Specify	  _________________________________	  
	  




10. How	  old	  are	  you?	  	  
	  
	  
11. What	  is	  your	  primary	  language?	  
 
12. What	  is	  your	  highest	  level	  of	  education?	  
 
13. What	  is	  your	  occupation?	  
 
14. Do	  you	  wear	  glasses	  or	  contacts?	  (If	  No,	  Skip	  #9)	  
Yes	   	   	   No	  
	  
15. If	  so,	  are	  you	  wearing	  your	  glasses	  or	  contacts	  today?	  














1. Do	  you	  currently	  take	  any	  over-­‐the-­‐counter	  medications?	  
Yes	   	   	   No	  
	  
2. Do	  you	  purchase	  or	  select	  your	  over-­‐the-­‐counter	  medications?	  
Yes   No 
 
3. Have	  you	  ever	  taken	  any	  of	  the	  following	  types	  of	  over-­‐the-­‐counter	  
medications?	  Select	  all	  that	  apply.	  
a. pain	  relievers	  such	  as	  Tylenol	  or	  Advil	  
b. medications	  for	  upset	  stomach	  or	  nausea	  such	  as	  Pepto	  Bismol	  
c. sinus	  medications	  such	  as	  Benadryl	  or	  Allegra	  





1. Do	  you	  use	  a	  computer	  often?	  	  	  
Yes   No 
 
2. How	  often	  do	  you	  use	  the	  computer	  each	  week?	  
a. 1	  -­‐	  2	  days	  per	  week	  
b. 3	  -­‐	  4	  days	  per	  week	  
c. 5	  or	  more	  days	  per	  week	  
	  
3. What	  type	  of	  tasks	  do	  you	  use	  your	  computer	  for?	  




e. Other:	  __________________________________	  
	  
4. Do	  you	  use	  a	  smart	  phone	  or	  tablet	  device	  often?	  	  	  
Yes	   	   	   No	  
	  






6. How	  often	  do	  you	  use	  the	  smart	  phone	  or	  tablet	  each	  week?	  
a. 1	  -­‐	  2	  days	  per	  week	  
b. 3	  -­‐	  4	  days	  per	  week	  
c. 5	  or	  more	  days	  per	  week	  
	  
7. What	  type	  of	  tasks	  do	  you	  use	  your	  smart	  phone	  or	  tablet	  for?	  




e. Other:	  _____________________________________	  
	  
8. If	  you	  use	  the	  Internet,	  how	  often	  do	  you	  use	  the	  Internet?	  
a. 1	  -­‐	  2	  days	  per	  week	  
b. 3	  -­‐	  4	  days	  per	  week	  
c. 5	  or	  more	  days	  per	  week	  
	  
9. How	  do	  you	  normally	  connect	  to	  the	  Internet	  (computer,	  phone)?	  
	  
	  
10. Do	  you	  use	  the	  Internet	  to	  search	  for	  information	  about	  prescription	  
medication?	  
Yes   No 
 
11. Do	  you	  use	  the	  Internet	  to	  search	  for	  information	  about	  over-­‐the-­‐counter	  
medication?	  





















Take a quick look of the medication information.  Based on your first thoughts, please 
answer the following questions. 
 
(Please Circle One) 
 
1) This	  information	  is	  	  
1. Very	  Difficult	  	  
2. Quite	  Difficult	  	  
3. Slightly	  Difficult	  
4. Neither	  Difficult	  or	  Easy	  
5. Slightly	  Easy	  
6. Quite	  Easy	  	  
7. Very	  Easy	  
 
(Please Circle One) 
 
2) Finding	  risks	  and	  warnings	  using	  this	  information	  would	  be	  	  
1. Very	  Difficult	  
2. Quite	  Difficult	  
3. Slightly	  Difficult	  
4. Neither	  Difficult	  or	  Easy	  
5. Slightly	  Easy	  
6. Quite	  Easy	  
7. Very	  Easy	  
 
(Please Circle One) 
 
3) If	  I	  wanted	  to,	  I	  could	  find	  risks	  and	  warnings	  using	  this	  information.	  
1. Strongly	  Disagree	  
2. Disagree	  
3. Mildly	  Disagree	  	  
4. Neither	  Disagree	  or	  Agree	  	  
5. Mildly	  Agree	  	  
6. Agree	  	  











1)	  Overall,	  how	  difficult	  was	  it	  for	  you	  to	  complete	  the	  questions	  (Circle	  One)?	  
8. Very	  Difficult	  
9. Quite	  Difficult	  
10. Slightly	  Difficult	  
11. Neither	  Difficult	  or	  Easy	  
12. Slightly	  Easy	  
13. Quite	  Easy	  
14. Very	  Easy	  
	  












3)	  Thinking	  about	  the	  information,	  was	  there	  any	  part	  of	  the	  information	  that	  






















1) Thinking	  about	  the	  two	  ways	  the	  information	  was	  presented,	  which	  do	  you	  











2) Thinking	  about	  the	  two	  ways	  the	  information	  was	  presented,	  which	  do	  you	  





























Oberservational Coding Sheet 




Medication # Control? # Times used support 
materials 
Task completion time 
Medication #1    
Medication #2    
Medication #3    






















Rapid Estimate of Adult Literacy in Medicine – Short Form (REALM-SF) 
Available on Internet: http://www.ahrq.gov/professionals/quality-patient-safety/quality-
resources/tools/literacy/index.html 
 
 
 
